
Contents
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Physiology and pharmacology Physiology and pharmacology
-
Analgesia for labour Analgesia for labour
-
Regional labour analgesia Regional labour analgesia
-
Indications Indications
-
Contraindications Contraindications
-
Relative contraindications Relative contraindications
-
Consent Consent
-
-
Epidural analgesia for labour Epidural analgesia for labour
-
Combined spinal epidural analgesia for labour (CSE) Combined spinal epidural analgesia for labour (CSE)
-
‘Walking’ epidurals ‘Walking’ epidurals
-
-
The poorly functioning epidural The poorly functioning epidural
-
Complications of epidural analgesia Complications of epidural analgesia
-
Hypotension Hypotension
-
Subdural block Subdural block
-
Total spinal Total spinal
-
Accidental IV injection of local anaesthetic Accidental IV injection of local anaesthetic
-
Neurological damage Neurological damage
-
Dural puncture See . Dural puncture See .
-
-
Dural puncture Dural puncture
-
Immediate management Immediate management
-
Late management Late management
-
Prophylactic treatment Prophylactic treatment
-
Symptomatic treatment Symptomatic treatment
-
Epidural blood patch, Epidural blood patch,
-
-
Remifentanil for labour analgesia Remifentanil for labour analgesia
-
Technique Technique
-
-
Caesarean section Caesarean section
-
Regional anaesthesia for Caesarean section Regional anaesthesia for Caesarean section
-
-
Caesarean section: epidural Caesarean section: epidural
-
Technique Technique
-
-
Caesarean section: spinal Caesarean section: spinal
-
Technique Technique
-
-
Caesarean section: combined spinal/epidural (CSE) Caesarean section: combined spinal/epidural (CSE)
-
Technique Technique
-
Needle-through-needle technique Needle-through-needle technique
-
Two needle technique Two needle technique
-
-
Special considerations Special considerations
-
-
Inadequate anaesthesia Inadequate anaesthesia
-
Preoperative inadequate block Preoperative inadequate block
-
Intraoperative inadequate block Intraoperative inadequate block
-
Spinal Spinal
-
Epidural/CSE Epidural/CSE
-
-
-
Hypotension Hypotension
-
Preload Preload
-
Pressor agents Pressor agents
-
-
Caesarean section: general anaesthesia Caesarean section: general anaesthesia
-
Technique Technique
-
Effect of general anaesthesia on the fetus Effect of general anaesthesia on the fetus
-
Failed intubation Failed intubation
-
-
Antacid prophylaxis Antacid prophylaxis
-
Elective surgery Elective surgery
-
Emergency surgery (if prophylaxis has not already been given) Emergency surgery (if prophylaxis has not already been given)
-
-
Postoperative analgesia Postoperative analgesia
-
Retained placenta Retained placenta
-
Breast feeding and drug transfer Breast feeding and drug transfer
-
Co-codamol and breast feeding Co-codamol and breast feeding
-
-
Placenta praevia and accreta Placenta praevia and accreta
-
Placenta praevia Placenta praevia
-
Placenta accreta Placenta accreta
-
Anaesthetic management Anaesthetic management
-
Technique Technique
-
-
Massive obstetric haemorrhage Massive obstetric haemorrhage
-
Aetiology of obstetric haemorrhage Aetiology of obstetric haemorrhage
-
Diagnosis Diagnosis
-
Management Management
-
Specific treatment for haemorrhage Specific treatment for haemorrhage
-
-
Amniotic fluid embolism Amniotic fluid embolism
-
Cardiac disease and pregnancy Cardiac disease and pregnancy
-
General principles General principles
-
-
Maternal resuscitation Maternal resuscitation
-
Pregnancy-induced hypertension, pre-eclampsia, and eclampsia, Pregnancy-induced hypertension, pre-eclampsia, and eclampsia,
-
Definitions Definitions
-
Pathophysiology Pathophysiology
-
Cardiorespiratory Cardiorespiratory
-
Haematological Haematological
-
Renal function Renal function
-
Cerebral function Cerebral function
-
Fetoplacental unit Fetoplacental unit
-
-
Management of pre-eclampsia Management of pre-eclampsia
-
Analgesia for vaginal delivery Analgesia for vaginal delivery
-
Anaesthesia for Caesarean section Anaesthesia for Caesarean section
-
General anaesthesia General anaesthesia
-
Regional anaesthesia Regional anaesthesia
-
-
-
Eclampsia Eclampsia
-
Immediate management Immediate management
-
Prevention of further fits Prevention of further fits
-
-
HELLP syndrome HELLP syndrome
-
Features of HELLP Features of HELLP
-
-
Surgery during pregnancy Surgery during pregnancy
-
General considerations General considerations
-
Teratogenicity Teratogenicity
-
Premedication Premedication
-
Induction agents Induction agents
-
Inhalational agents Inhalational agents
-
Analgesics Analgesics
-
-
Cervical cerclage Cervical cerclage
-
Preoperative Preoperative
-
Perioperative Perioperative
-
Postoperative Postoperative
-
Special considerations Special considerations
-
-
Controversies Controversies
-
Feeding in labour Feeding in labour
-
Epidurals, dystocia, and Caesarean section Epidurals, dystocia, and Caesarean section
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Cite
James Eldridge
Physiology and pharmacology 736
Analgesia for labour 738
Regional labour analgesia 739
Epidural analgesia for labour 740
The poorly functioning epidural 744
Complications of epidural analgesia 746
Dural puncture 748
Remifentanil for labour analgesia 752
Caesarean section 754
Caesarean section: epidural 756
Caesarean section: spinal 758
Caesarean section: combined spinal/epidural (CSE) 760
Inadequate anaesthesia 762
Hypotension 763
Caesarean section: general anaesthesia 764
Antacid prophylaxis 766
Postoperative analgesia 767
Retained placenta 768
Breast feeding and drug transfer 770
Placenta praevia and accreta 772
Massive obstetric haemorrhage 774
Amniotic fluid embolism 777
Cardiac disease and pregnancy 778
Maternal resuscitation 780
Pregnancy-induced hypertension, pre-eclampsia, and eclampsia 782
Eclampsia 787
HELLP syndrome 788
Surgery during pregnancy 790
Cervical cerclage 794
Controversies 796
See also:
Obstetric anaesthesia in the patient with a spinal cord injury 254
Physiology and pharmacology
From early in the first trimester of pregnancy, a woman's physiology changes rapidly, predominantly under the influence of increasing progesterone production by the placenta. The effects are widespread.
Cardiac output increases by ∼50%. Diastolic blood pressure falls in early to mid-trimester and returns to prepregnant levels by term. Systolic pressure, although following the same pattern, is less affected. Central venous and pulmonary arterial wedge pressures are not altered.
Cardiac output increases further in labour, even with effective epidural analgesia, peaking immediately after delivery. It is in this period, when the preload and afterload of the heart are changing rapidly, that women with impaired myocardial function are at greatest risk.
Uteroplacental blood flow is not autoregulated and so is dependent on uterine blood pressure.
Aortocaval occlusion occurs when the gravid uterus rests on the aorta or the inferior vena cava. Even in the absence of maternal hypotension, placental blood supply may be compromised in the supine position. After the 20th week of gestation, a left lateral tilt should always be employed. If either mother or fetus is symptomatic, the degree of tilt should be increased.
Plasma volume increases 50% by term while the red cell mass only increases by 30%, resulting in the physiological anaemia of pregnancy.
Pregnant women become hypercoagulable early in the first trimester. Antepartum maternal deaths from pulmonary embolism occur most commonly in the first trimester. Plasma concentrations of Factors I, VII, VIII, IX, X, and XII are all increased. Antithrombin III levels are depressed.
PaCO2 falls to ∼4.0kPa (30mmHg). Functional residual capacity is reduced by 20% resulting in airway closure in 50% of supine women at term. This, in combination with a 60% increase in oxygen consumption, renders pregnant women at term vulnerable to hypoxia when supine.
In labour painful contractions and excessive breathing of Entonox can result in further hyperventilation and marked alkalosis may occur. Arterial pH in excess of 7.5 is common.
Gastric emptying and acidity are little changed by pregnancy. However, gastric emptying is slowed in established labour and almost halted if systemic opioids are administered for analgesia. Barrier pressure (the difference in pressure between the stomach and lower oesophageal ‘sphincter’) is reduced, but the incidence of regurgitation into the upper oesophagus during anaesthesia, in otherwise asymptomatic individuals, is not significantly different in the first and second trimesters.
By 48hr postpartum, intra-abdominal pressure, gastric emptying, volume, and acidity are all similar to non-pregnant controls. Although lower oesophageal sphincter tone may take longer to recover, mask anaesthesia is acceptable 48hr after delivery in the absence of other specific indications for intubation.1
Renal blood flow increases by 75% at term and glomerular filtration rate by 50%. Both urea and creatinine plasma concentrations fall.
Neurological tissue has a greater susceptibility to the action of local anaesthetics during pregnancy—‘MAC’ is also reduced.
The volume of distribution increases by 5 litres, affecting predominantly polar (water-soluble) agents. Lipid-soluble drugs are more affected by changes in protein binding. The fall in albumin concentration increases the free active portion of acidic agents, while basic drugs are more dominantly bound to α1 glycoprotein. Some specific binding proteins such as thyroxin binding protein increase in pregnancy.
Although plasma cholinesterase concentration falls by about 25% in pregnancy, this is counteracted by an increase in volume of distribution, so the actual duration of action of agents such as suxamethonium is little changed.
Analgesia for labour
The analgesic agents commonly employed in labour are inhaled nitrous oxide, opioids, and regional techniques.
Randomised studies show only weak evidence of analgesia for transcutaneous electrical nerve stimulation (TENS). Opioids in labour act predominantly as sedatives and amnesics—pain scores are minimally changed. Entonox is more efficacious than pethidine, but complete analgesia is never attained. When regional analgesia is contraindicated, a fentanyl or remifentanil PCA may be beneficial. Diamorphine has also been advocated.
Regional analgesia provides the most effective pain relief. If hypotension is avoided, fetal condition in the first stage of labour may be improved as maternal sympathetic stimulation and hyperventilation are reduced. However, a degree of maternal motor block is almost universal, and most randomised studies comparing regional and parenteral analgesia demonstrate an association between epidural analgesia and prolonged labour, together with a higher incidence of instrumental deliveries. Careful obstetric management of labour and appropriate anaesthetic management of analgesia may negate this effect.1
Uterine pain is transmitted in sensory fibres which accompany sympathetic nerves and end in the dorsal horns of T10–L1. Vaginal pain is transmitted via the S2–S4 nerve roots (the pudendal nerve). Spinal, combined spinal/epidural (CSE), and epidural analgesia have largely replaced other regional techniques (paracervical, pudendal, caudal block). Neuraxial techniques can be expected to provide effective analgesia in over 85% of women.
Acceptable analgesia must be provided, but minimising the incidence of hypotension and motor blockade is important. Reducing the degree of motor block increases maternal satisfaction and may decrease the incidence of assisted delivery. Motor block can be reduced by:
Using synergistic agents such as opioids to reduce the dose of local anaesthetic administered.
Establishing regional analgesia with low-dose epidural local anaesthetic and opioid or low-dose intrathecal local anaesthetic and opioid.
Using patient-controlled epidural analgesia (PCEA) or intermittent top-ups to maintain analgesia. In general, infusions deliver a greater total dose of local anaesthetic than intermittent top-ups, while PCEA delivers the smallest total dose.
The choice of local anaesthetic may also affect motor block. At equimolar doses, ropivacaine produces less motor block than bupivacaine, but it is not as potent as bupivacaine and the relative motor block at equipotent doses remains controversial.
Regional labour analgesia
Indications
Maternal request.
Expectation of operative delivery (e.g. multiple pregnancy, malpresentation).
Maternal disease—in particular, conditions in which sympathetic stimulation may cause deterioration in maternal or fetal condition.
Specific cardiovascular disease (e.g. regurgitant valvular lesions).
Severe respiratory disease (e.g. cystic fibrosis).
Specific neurological disease (intracranial A–V malformations, etc.).
Obstetric disease (e.g. pre-eclampsia).
Conditions in which GA may be life threatening (e.g. morbid obesity).
Contraindications
Maternal refusal.
Allergy (true allergy to amide local anaesthetics is rare).
Local infection.
Uncorrected hypovolaemia.
Coagulopathy. (Although guidelines suggest that with platelet count >80 × 109/l and INR <1.4 neuraxial procedures are safe, clinical judgement for each individual patient remains of paramount importance. The cause of the clotting abnormality and the indication for the procedure have to be considered.)
Relative contraindications
Expectation of significant haemorrhage.
Untreated systemic infection (providing systemic infection has been treated with antibiotics, the risk of ‘seeding’ infection into the epidural space with neuraxial procedures is minimal).
Specific cardiac disease (e.g. severe valvular stenosis, Eisenmenger's syndrome, peripartum cardiomyopathy). Although regional analgesia has been used for many of these conditions, extreme care must be taken to avoid any rapid changes in blood pressure, and preload and afterload of the heart. Intrathecal opioid without local anaesthetic may be advantageous for these patients.
‘Bad backs’ and previous back surgery do not contraindicate regional analgesia/anaesthesia, but scarring of the epidural space may limit the effectiveness of epidural analgesia and increase the risk of inadvertent dural puncture. Intrathecal techniques can be expected to work normally.
Consent
Most UK anaesthetists do not take written consent before inserting an epidural for labour analgesia, but ‘appropriate’ explanation must be given. The information offered varies according to local guidelines and with the degree of distress of each individual woman. The explanation and, in particular, the possible hazards discussed must be documented, as many women do not accurately recall information given in labour. Information about labour analgesia should always be available antenatally.
Epidural analgesia for labour
Scrupulous attention to sterile technique is required. Mask, gown, and gloves should be worn.1
Establish IV access. In the absence of previous haemorrhage or dehydration, when low-dose local anaesthetic techniques are used, large fluid preloads are unnecessary.
Position in either a full lateral or sitting position. Finding the midline in the obese may be easier in the sitting position. Accidental dural puncture may be slightly lower in the lateral position.
Fetal heart rate should be recorded before and during the establishment of analgesia. Whether regional analgesic technique requires routine continuous fetal heart rate monitoring after analgesia has been established is controversial.
Skin sterilisation with chlorhexidine is more effective than with iodine.
Locate the epidural space (loss of resistance to saline may have slight advantages in both reduced incidence of accidental dural puncture and reduced incidence of ‘missed segments’ compared with loss of resistance to air).
Introduce 4–5cm of catheter into the epidural space. (Longer has an increased incidence of unilateral block and shorter increases the chance that the catheter pulls out of the space.) Multihole catheters have a lower incidence of unsatisfactory blocks.
Check for blood/CSF.
Give appropriate test dose. An ‘appropriate’ test remains controversial. Using 0.5% bupivacaine significantly increases motor block. Using 1:200 000 adrenaline to detect IV placement of a catheter has both high false-positive and false-negative rates. Many anaesthetists will use 10–15ml 0.1% bupivacaine with a dilute opioid (2µg/ml fentanyl) as both the test and main dose. This will exclude intrathecal placement but may give false negatives if the catheter is sited intravascularly. The complete absence of a detectable block after a normal epidural loading dose for labour analgesia should therefore warn of possible IV cannulation. Remember every dose is a ‘test dose’! If required give further local anaesthetic to establish analgesia. There should be no need to use concentrations >0.25% bupivacaine.
If required give further local anaesthetic to establish analgesia. There should be no need to use concentrations >0.25% bupivacaine.
Measure maternal blood pressure every 5min for at least 20min after every bolus dose of local anaesthetic.
Once the epidural is functioning it can be maintained by one of three methods:
Intermittent top-ups of local anaesthetic administered by midwives (5–10ml 0.25% bupivacaine or 10–15ml 0.1% bupivacaine with 2µg/ml fentanyl).
A continuous infusion of local anaesthetic (5–12ml/hr of 0.0625–0.1% bupivacaine with 2µg/ml fentanyl).
Intermittent top-ups of local anaesthetic administered by a PCEA (5ml boluses of 0.0625–0.1% bupivacaine with 2µg/ml fentanyl and a 10–15min lockout period).
Combined spinal epidural analgesia for labour (CSE)
A combination of low-dose subarachnoid local anaesthetic and/or opioid together with subsequent top-ups of weak epidural local anaesthetic produces a rapid onset with minimal motor block and effective analgesia. An epidural technique alone can produce a similar degree of analgesia and motor block, but may take 10–15min longer to establish. CSE can be performed as a needle-through-needle technique or as separate injections in the same or in different intervertebral spaces:
Locate epidural space at the L3/4 interspace with a Tuohy needle. Pass a 25–27G pencil-point needle through the Tuohy needle to locate the subarachnoid space.
Inject subarachnoid solution (e.g. 0.5–1.0ml 0.25% bupivacaine with 5–25µg fentanyl). Do not rotate epidural needle. Insert epidural catheter
or
Perform spinal at L3/4 with a 25–27G pencil-point needle.
Inject subarachnoid solution.
Perform epidural once analgesia has been established.
Caution: the epidural catheter cannot be effectively tested until the subarachnoid analgesia has receded.
When the first top-up is required (usually 60–90min after the spinal injection), give the epidural test dose (e.g. 10–15ml 0.1% bupivacaine with 2µg/ml fentanyl).
Further management of the epidural is the same as for epidural analgesia alone.
‘Walking’ epidurals2
Effective analgesia with minimal motor block of the lower limbs can be readily produced with low doses of epidural or intrathecal local anaesthetic, usually in combination with an opioid (e.g. subarachnoid injection of 1ml 0.25% bupivacaine with 10–25µg fentanyl or an epidural bolus of 15–20ml 0.1% bupivacaine with 2µg/ml fentanyl. Subsequent epidural top-ups of 15ml of the same solution as required).
In some centres women with minimal motor blockade are encouraged to mobilise. The possible advantages of these techniques include:
The vertical position, without epidural anaesthesia, is associated with shorter labour, possibly less fetal distress, and greater maternal preference. However, the vertical position and mobility do not reduce the need for forceps delivery and the advantages have not been substantiated when walking with epidural analgesia.
Minimal motor block associated with these techniques increases maternal satisfaction scores. Intrathecal, as opposed to epidural, techniques produce a more rapid onset of analgesia, possibly a more rapid cervical dilation, and a marginal reduction in assisted delivery.
Mobilisation has been criticised because:
Women usually have adequate leg strength, but it is rarely complete and is likely to become increasingly compromised with repeat doses of epidural local anaesthetic.
Impaired proprioception may make walking dangerous even when leg strength has been maintained. Whilst dynamic posturography suggests that following an initial intrathecal dose of 2.5mg bupivacaine and 10µg fentanyl, proprioception is adequate for safe walking, this may no longer be true after repeated epidural top-ups.
Intrathecal opioid may cause temporary fetal bradycardia, probably by altering uterine blood flow through a change in maternal spinal reflexes.
Assessing fetal condition is difficult when the mother is mobile.
In practice, when a technique that is likely to permit walking is used, only approximately 50% of women who could walk actually choose to do so. Despite this most women prefer the added sense of control that is engendered by retaining leg strength. If women are to be allowed to walk, always wait at least 30min from the initiation of the block before attempting mobilisation. Then:
Check strength of straight leg raising in bed.
Ask the woman if she feels able to stand.
When the woman first stands, have two assistants ready to offer support if required.
Perform a knee bend.
Ask the woman if she feels safe.
Allow full mobilisation.
After each top-up the same sequence must be repeated.
The poorly functioning epidural
Look for the pattern of failure. Remember that a full bladder may cause breakthrough pain. Ask the midwife if a full bladder is likely. Carefully assess the spread of the block. It is important to be confident that the epidural could be topped up for a Caesarean section if required. Therefore, if in doubt, resite the epidural.
Pattern of failure . | Remedy . |
---|---|
Global failure No detectable block despite at least 10ml 0.25% bupivacaine (or equivalent) | Resite epidural |
Partial failure Unilateral block: feel both feet to assess whether they are symmetrically warm and dry. See if the pattern matches the distribution of pain | Top-up epidural with painful side in a dependent position (Use local anaesthetic and 50–100µg fentanyl) Withdraw catheter 2–3cm and give a further top-up Resite epidural |
Missed segment: true missed segments are rare. Commonly a ‘missed segment’ felt in the groin is a partial unilateral block | Top-up with opioid (i.e. 50–100µg fentanyl). The intrathecal mode of action will minimise segmental effects Continue as per ‘unilateral block’ |
Back pain: severe back pain is associated with an occipito-posterior position of the fetus and may require a dense block to establish analgesia | Top-up with more local anaesthetic and opioid |
Perineal pain | Check sacral block and that the bladder is empty Top-up with more local anaesthetic in sitting position Continue as per unilateral block |
Pattern of failure . | Remedy . |
---|---|
Global failure No detectable block despite at least 10ml 0.25% bupivacaine (or equivalent) | Resite epidural |
Partial failure Unilateral block: feel both feet to assess whether they are symmetrically warm and dry. See if the pattern matches the distribution of pain | Top-up epidural with painful side in a dependent position (Use local anaesthetic and 50–100µg fentanyl) Withdraw catheter 2–3cm and give a further top-up Resite epidural |
Missed segment: true missed segments are rare. Commonly a ‘missed segment’ felt in the groin is a partial unilateral block | Top-up with opioid (i.e. 50–100µg fentanyl). The intrathecal mode of action will minimise segmental effects Continue as per ‘unilateral block’ |
Back pain: severe back pain is associated with an occipito-posterior position of the fetus and may require a dense block to establish analgesia | Top-up with more local anaesthetic and opioid |
Perineal pain | Check sacral block and that the bladder is empty Top-up with more local anaesthetic in sitting position Continue as per unilateral block |
Complications of epidural analgesia
Hypotension
In the absence of fetal distress, a fall in systolic blood pressure of 20% or to 100mmHg (whichever is higher) is acceptable. However, uterine blood flow is not autoregulated and prolonged or severe hypotension will cause fetal compromise. Preload is not routinely required when using low doses of local anaesthetic, but patients should not be hypovolaemic before instituting regional analgesia. When hypotension is detected it should be treated quickly:
Avoid aortocaval occlusion—make sure that the patient is in the full lateral position.
Measure the blood pressure on the dependent arm.
Give an IV fluid bolus of crystalloid solution.
Give 6mg IV ephedrine and repeat as necessary.
Remember that brachial artery pressure may not reflect uterine artery blood flow. If fetal distress is detected, and is chronologically related to a regional anaesthetic procedure, treat as above even in the absence of overt hypotension.
Subdural block1
Subdural block occurs when the epidural catheter is misplaced between the dura mater and arachnoid mater. In obstetric practice, the incidence of clinically recognised subdural block is less than 1:1000 epidurals. However, subdural blocks may be clinically indistinguishable from epidural blocks. Definitive diagnosis is radiological. The characteristics of a subdural block are:
A slow onset (20–30min) of a block that is inappropriately extensive for the volume of local anaesthetic injected. The block may extend to the cervical dermatomes and Horner's syndrome may develop.
Block is often patchy and asymmetrical. Sparing of motor fibres to the lower limbs may occur.
A total spinal may occur following a top-up dose. This is likely to be a consequence of the increased volume rupturing the arachnoid mater.
If a subdural is suspected resite the epidural catheter.
Total spinal
The incidence of total spinal is variously reported to be 1:5000 to 1:50 000 epidurals. Usually the onset is rapid, although delays of 30min or more have been reported. Delayed onset may be related to a change in maternal position, or a subdural catheter placement. Symptoms are of a rapidly rising block. Initially difficulty in coughing may be noted (commonly seen in regional anaesthesia for Caesarean section), then loss of hand and arm strength, followed by difficulty with talking, breathing, and swallowing. Respiratory paralysis, cardiovascular depression, unconsciousness, and finally fixed dilated pupils ensue. Unsurprisingly total spinals are reported more often after epidural anaesthesia than epidural analgesia, as larger doses of local anaesthetic are employed.
Management of total spinal is as follows:
Maintain airway and ventilation, avoid aortocaval compression, and provide cardiovascular support.
Even if consciousness is not lost, intubation may be required to protect the airway.
Careful maternal and fetal monitoring is essential and, if appropriate, delivery of the fetus. In the absence of fetal distress, Caesarean section is not an immediate requirement. Ventilation is usually necessary for 1–2hr.
Accidental IV injection of local anaesthetic2
‘Every dose is a test dose.’ The maxim is to avoid injecting any single large bolus of local anaesthetic IV. Remember that IV or partial IV positioning of epidural catheters occurs in at least 5% of epidurals. The risk can be minimised by:
Meticulous attention to technique during placement. Always check for blood in the catheter.
Always being alert to symptoms of IV injection with every dose of local anaesthetic, even when previous doses have been uncomplicated.
Divide all large doses of local anaesthetic into aliquots.
Use appropriate local anaesthetics.
See treatment of local anaesthetic toxicity ( p. 1182).
Neurological damage
Neurological damage does occur after childbirth, but establishing cause and effect is difficult. Neurological sequelae following delivery under general anaesthesia is as common as delivery under regional anaesthesia, suggesting that obstetric causes of neurological problems are probably more common than any effects from the regional technique. Prolonged neurological deficit after epidural anaesthesia occurs in approximately 1:10 000 to 1:15 000. Major neurological damage probably occurs in less than 1:80 000 neuraxial procedures in the obstetric population, and this group of patients probably has the lowest risk of any patient population.2
Dural puncture See p. 748.
Dural puncture
When loss of CSF is greater than production, as might occur through a dural tear, CSF pressure falls and the brain sinks, stretching the meninges. This stretching is thought to cause headache. Compensatory vasodilation of intracranial vessels may further worsen symptoms.
The incidence of dural puncture should be less than 1% of epidurals. All midwives, as well as obstetric and anaesthetic staff, should be alert to the signs of post dural puncture headache, as symptoms may not develop for several days. If untreated, headaches are not only unpleasant but also very rarely can be life threatening, usually as a result of intracranial haemorrhage or coning of the brainstem.
Management of accidental dural puncture can be divided into immediate and late.
Immediate management
The initial aim is to achieve effective analgesia without causing further complication.
Either:
If a dural puncture occurs, pass the ‘epidural’ catheter into the subarachnoid space.
Label the catheter clearly as an intrathecal catheter and only allow the anaesthetist to perform top-ups.
Give intermittent top-ups through the catheter. (1ml 0.25% bupivacaine ±5–25µg fentanyl. Tachyphylaxis may occur with prolonged labour.)
Advantages:
The analgesia produced is likely to be excellent.
There is no possibility of performing another dural puncture on reinsertion of the epidural.
The unpredictable spread of epidural solution through the dural tear is eliminated.
The incidence of post dural puncture headache may be reduced (but only if the catheter is left in for more than 24hr).
Disadvantages:
The catheter cannot be used to perform an early blood patch.
There is a theoretical risk of introducing infection.
The catheter may be mistaken for an epidural catheter.
Or:
Remove the epidural catheter.
Reinsert the epidural at a different interspace—usually one interspace higher. If the reason for tap was difficult anatomy, a senior colleague should take over.
Run the epidural as normal, but beware of intrathecal spread of local anaesthetic. All top-ups should be given by an anaesthetist.
With either technique the patient should be informed at the earliest opportunity that a dural puncture has occurred and of the likely sequelae. Labour itself may be allowed to continue normally. Arrange daily postnatal follow-up.
Late management
Following a dural puncture with a 16–18G Tuohy needle, the incidence of post dural puncture headache is approximately 70%. Not all dural punctures are recognised in labour so be alert to the possibility, even in women who had uncomplicated epidural analgesia. Headaches in the postnatal period are common. The key differentiating factor between a ‘normal’ postnatal headache and a post dural puncture headache is the positional nature of the latter.
Common features of post dural puncture headache include:
Typically onset is 24–48hr post dural puncture. Untreated they are said to last 7–10d, but the evidence is poor.
Characteristically worse on standing. Headache is often absent after overnight bed rest but returns after mobilising.
Usually in the fronto-occipital regions and may be associated with neck stiffness.
Photophobia and difficulty in accommodation are common. Hearing loss, tinnitus, and VIth nerve palsy with diplopia are possible.
Nausea occurs in up to 60% of cases.
Treatment is either to alleviate symptoms while waiting for the dural tear to heal itself or to seal the puncture. Epidural blood patching is the only commonly used method of sealing dural tears, although neurosurgical closure has been reported.
Prophylactic treatment1
The most effective prophylactic treatment is blood patching. At the end of labour, 20ml of blood can be injected through the epidural catheter (having removed the epidural filter). All residual block must have worn off before performing a prophylactic patch as radicular pain is an indication to stop injecting. However, early blood patching has a lower success rate and bacteraemia is common immediately after delivery (7% rising to 80% with uterine manipulation). Blood patching is not without sequelae and the Cochrane database review discourages the use of prophylactic blood patches.
Bed rest alleviates symptoms, but the incidence of post dural puncture headache after 48hr is the same for those cases that mobilised throughout. Because of the risk of thromboembolism, bed rest should not be routinely encouraged in asymptomatic women.
Epidural infusion of saline (1 litre/24hr) will compress the dural sac and can alleviate symptoms. It may also reduce the flow of CSF through a dural tear. After 24hr of continuous infusion the incidence of post dural puncture headache is marginally reduced. However, radicular pain in the lower limbs may occur and patients are immobilised.
Symptomatic treatment
Simple analgesics (paracetamol, NSAIDs, codeine) are the mainstays of symptomatic treatment. They should always be offered, even though they are unlikely to completely relieve severe post dural puncture headache.
Adequate fluid intake should be encouraged although there is no evidence that hydration reduces the incidence of post dural puncture headache.
Caffeine/theophyllines have become controversial. Concern has been expressed that the incidence of seizures following dural puncture may be increased in the presence of caffeine. These drugs act by reducing intracranial vasodilation, which is partially responsible for the headache. However, while symptoms may be improved, they are not cured. Therefore it is probably sensible to avoid using these agents.
Sumatriptan. Although this cerebral vasoconstrictor is of benefit, it is expensive, is given subcutaneously (6mg), and may cause coronary artery spasm. Its use is best reserved for those in whom blood patching is contraindicated.
Epidural blood patch—see below.
Epidural blood patch performed around 48hr post partum has a 60–90% cure rate at the first attempt (recent studies that have followed women for more than 48hr have found lower success rates). The proposed mechanism of action is twofold:
Blood injected into the epidural space compresses the dural sac and raises the intracranial pressure. This produces an almost instantaneous improvement in pain.
The injected blood forms a clot over the site of the dural tear and this seals the CSF leak.
Blood injected into the epidural space predominantly spreads cephalad, so blood patches should be performed at the same or lower interspace as the dural puncture. Suggestions that labour epidurals after blood patching may be less effective have not been confirmed.
Consent must be obtained. The patient should be apyrexial and not have a raised white cell count.
Two operators are required. One should be an experienced ‘epiduralist’, the other is required to take blood in a sterile manner.
The patient should have a period of bed rest before performing the patch to reduce the CSF volume in the epidural space.
Aseptic technique must be meticulous both at the epidural site and the site of blood letting (usually the antecubital fossa).
An epidural should be performed at the same or a lower vertebral interspace as the dural puncture with the woman in the lateral position to minimise CSF pressure in the lumbar dural sac.
Once the epidural space has been identified, 20ml of blood is obtained.
Inject the blood slowly through the epidural needle until either a maximum of 20ml has been given or pain develops (commonly in the back or legs). If pain occurs, pause and if the pain resolves, try continuing with slow injection. If the pain does not resolve or recurs, then stop.
To allow the clot to form, maintain bed rest for at least 2hr and then allow slow mobilisation.
As far as possible the patient should avoid straining, lifting, or excessive bending for 48hr, although there are obvious limitations when a woman has a newborn infant to care for.
Follow-up is still required. Every woman should have clear instructions to contact the anaesthetists again if symptoms recur even after discharge home.
Serious complications of blood patching are rare. However, backache is common, with 35% of women experiencing some discomfort 48hr post epidural blood patch and 16% of women having prolonged backache (mean duration 27d). Other reported complications include repeated dural puncture, neurological deficits, epileptiform fits, and cranial nerve damage.
Remifentanil for labour analgesia
Remifentanil is an ultrashort-acting µ agonist opioid, which is broken down by tissue and plasma esterases. It has an analgesia half life of about 6min and a rapid onset time of 30–60s. Although remifentanil readily crosses the placenta, it is rapidly metabolised in the fetus. These features make remifentanil a potentially useful analgesic agent in labour. Like all opioids, it does not produce complete analgesia, but when compared with pethidine, remifentanil PCA is associated with better pain relief and greater patient satisfaction.1 However, remifentanil has the potential to cause significant respiratory depression/maternal sedation and so should only be used with careful supervision. The ideal PCA regimen has not been established. Many proposed techniques are based on body weight, but the technique below is based on a fixed dose which has the advantage of simplicity. The addition of nitrous oxide may improve analgesia further but may increase the risk of hypoxaemia.1
Technique
Establish one-to-one care with a trained individual (midwife).
No opioid should have been used in the previous 4hr.
Establish dedicated IV access.
PCA with bolus dose of 40µg and lockout of 2min.
Monitor with continuous pulse-oximetry.
Give O2 if SpO2 <94% on air.
30min observations of respiratory rate, sedation score, and pain scores.
Always flush the cannula when PCA is discontinued.
Call the anaesthetist if:
The patient is not rousable to voice.
Respiratory rate <8 breaths/min.
SpO2 <94% despite O2 supplementation.
Caesarean section
With all Caesarean sections, it is vital that the obstetrician clearly communicates the degree of urgency to all staff. A recommended classification is:1
Emergency | There is immediate threat to the life of mother or fetus. |
Urgent | Maternal or fetal compromise that is not immediately life threatening. |
Scheduled | No maternal or fetal compromise, but needs early delivery. |
Elective | Delivery timed to suit mother and staff. |
Emergency | There is immediate threat to the life of mother or fetus. |
Urgent | Maternal or fetal compromise that is not immediately life threatening. |
Scheduled | No maternal or fetal compromise, but needs early delivery. |
Elective | Delivery timed to suit mother and staff. |
For all emergency Caesarean sections, the patient must be transferred to theatre as rapidly as possible. Fetal monitoring should be continued until abdominal skin preparation starts. In most centres, general anaesthesia is used when an ‘immediate’ Caesarean section is required, but ‘urgent’ Caesarean sections are usually performed under regional anaesthesia.
There is an expectation that the decision to delivery time should be less than 30min when the indication for Caesarean section is fetal distress. However, delivery before this time limit is no guarantee of a successful outcome and delivery after this limit does not necessarily mean disaster. Each case must be individually assessed and the classification of urgency continuously reviewed.
Regional anaesthesia for Caesarean section
Regional anaesthesia for Caesarean section was initially driven by maternal preference. However, regional anaesthesia is also safer than general anaesthesia.2
Advantages of regional anaesthesia include:
Improved safety for mother with minimal risk of aspiration and lower risk of anaphylaxis.
The neonate is more alert, promoting early bonding and breastfeeding.
Fewer drugs are administered, with less ‘hangover’ than after general anaesthesia.
Better postoperative analgesia and earlier mobilisation.
Both mother and partner can be present at the delivery.
Although regional anaesthesia is safer, maternal refusal remains a contraindication. Although it is reasonable to give nervous mothers a clear explanation of the advantages and disadvantages, mothers should not be forced into accepting regional anaesthesia.
Three techniques are available—epidural, spinal, and combined spinal epidural. Epidural is most commonly used for women who already have epidural analgesia in labour. Spinal is the most popular technique for elective Caesarean section, although in some centres combined spinal epidurals are preferred. Whatever technique is chosen, a careful history and appropriate examination should be performed. This should include checking:
Blood group and antibody screen. Routine crossmatching of blood is not required unless haemorrhage is expected or if antibodies that interfere with crossmatching are present.
Ultrasound reports to establish the position of the placenta. A low-lying anterior placenta puts a woman at risk of major haemorrhage, particularly if associated with a scar from a previous Caesarean section.
An explanation of the technique must be offered. Although Caesarean section under regional anaesthesia becomes routine for the anaesthetist, it is rarely routine for the mother. Reassurance and support are important. The possibility of complications must also be mentioned—in particular, the possibility of intraoperative discomfort and its management. Pain during regional anaesthesia is now a leading obstetric anaesthetic cause of maternal litigation. Document all complications that are discussed. Neonates are usually more alert after regional than general anaesthesia. However, the speed of onset of sympathectomy that occurs with spinal anaesthesia (as opposed to epidural) results in a greater fall in maternal cardiac output and blood pressure and may be associated with a more acidotic neonate at delivery. In conditions where sudden changes in afterload may be dangerous (i.e. stenotic valvular heart disease) the speed of onset of a spinal block can be slowed by:
Careful positioning during the onset of the block.
Using an intrathecal catheter and incrementally topping up the block.
Using a combined spinal epidural approach and injecting a small dose of intrathecal local anaesthetic. The block can be subsequently extended using the epidural catheter.
While a slow onset of block may be preferable in elective Caesarean section, a rapid onset is necessary for emergency cases. Spinal anaesthesia provides a better quality of analgesia and is quicker in onset than epidural anaesthesia.1
Caesarean section: epidural
Advantages . | Disadvantages . |
---|---|
Easy to top-up labour epidural Stable BP Intraoperative top-up possible Epidural can be used for postop analgesia | Slow onset Large doses of LA Poorer quality of block than spinal anaesthesia |
Advantages . | Disadvantages . |
---|---|
Easy to top-up labour epidural Stable BP Intraoperative top-up possible Epidural can be used for postop analgesia | Slow onset Large doses of LA Poorer quality of block than spinal anaesthesia |
Indications for Caesarean section under epidural anaesthesia are as follows:
Women who already have epidural analgesia established for labour.
Specific maternal disease (e.g. cardiac disease) where rapid changes in systemic vascular resistance might be problematic.
Technique
History/examination/explanation and consent.
Ensure that antacid prophylaxis has been given.
Establish 16G or larger IV access. Start 10–15ml/kg crystalloid co-load.
Insert epidural catheter at the L2/3 or L3/4 vertebral interspace.
Test dose, then incrementally top-up the epidural with local anaesthetic and opioid:
5–8ml boluses of 2% lidocaine with 1:200 000 adrenaline every 2–3min up to a maximum of 20ml (mix 19ml 2% lidocaine with 1ml 1:10 000 adrenaline rather than using preparatory mixture which contains preservative and has a lower pH).
or:
5ml 0.5% bupivacaine/levobupivacaine/ropivacaine every 4–5min up to a maximum of 2mg/kg in any 4hr period. (The single enantiomer local anaesthetics may offer some safety advantage; however, lidocaine is still safer than both ropivacaine and levobupivacaine.)
Opioid (e.g. 100µg fentanyl or 2.5mg diamorphine) improves the quality of the analgesia and a lower level of block may be effective if opioid has been given.
Establish an S4–T4 block (nipple level) measured by loss of light touch sensation. Always check the sacral dermatomes, as epidural local anaesthetic occasionally does not spread caudally. Anaesthesia to light touch is more reliable at predicting adequacy of block than loss of cold sensation.1 Document the level of block obtained and the adequacy of perioperative analgesia.
Position patient in the supine position with a left lateral tilt or wedge. Give supplemental oxygen by facemask if SpO2 <96% on air. (This is very important in obese patients who may become hypoxic when supine, and may have benefit for a compromised fetus.)
Treat hypotension with (see also p. 763):
Fluid (colloid more effective than crystalloid).
50–100µg phenylephrine IV bolus (expect a reflex bradycardia) or 6mg ephedrine IV. α-agonists may be more effective and be associated with less fetal acidosis than ephedrine.
Increasing the left uterine displacement.
At delivery give 5IU oxytocin IV bolus. If tachycardia must be avoided then an IV infusion of 30–50IU oxytocin in 500ml crystalloid given over 4hr is an acceptable alternative.
At the end of the procedure give NSAID unless contraindicated (100mg diclofenac PR).1
Epidural diamorphine given at the time of surgery improves postoperative analgesia, while epidural fentanyl has little postoperative analgesic benefit.
Caesarean section: spinal
Advantages . | Disadvantages . |
---|---|
Quick onset Good quality analgesia Easy to perform | Single shot Limited duration Inadequate analgesia is difficult to correct Rapid changes in BP and cardiac output |
Advantages . | Disadvantages . |
---|---|
Quick onset Good quality analgesia Easy to perform | Single shot Limited duration Inadequate analgesia is difficult to correct Rapid changes in BP and cardiac output |
Spinal anaesthesia is the most commonly used technique for elective Caesarean sections. It is rapid in onset, produces a dense block, and with intrathecal opioids can produce long-acting postoperative anal gesia. However, hypotension is much more common than with epidural anaesthesia.
Technique
History/examination/explanation and consent.
Ensure that antacid prophylaxis has been given.
Establish 16G or larger IV access. Start 10–15ml/kg crystalloid co-load.
Perform spinal anaesthetic at L3/4 interspace using a 25G or smaller pencil-point needle. With the orifice pointing cephalad, inject the anaesthetic solution, e.g. 2.5ml 0.5% hyperbaric bupivacaine with 300µg diamorphine or 15µg fentanyl. Intrathecal diamorphine improves postoperative analgesia, while intrathecal fentanyl has little postoperative analgesic benefit. (Preservative-free morphine 100µg is also used but has little intraoperative benefit. Morphine provides prolonged postoperative analgesia but with a higher incidence of postoperative nausea and vomiting, plus an increased risk of late respiratory depression.)
During the insertion of a spinal anaesthetic, some anaesthetists place patients in a sitting position, while others lie patients on their side. The sitting position usually makes the midline easier to find (important in obese patients), and may be associated with a faster onset, although the height of block is less predictable. A lateral position is associated with a slower onset of block, particularly if a full lateral position is maintained until the block has fully developed. This position also avoids aortocaval compression. With both positions, when hyperbaric local anaesthetic solutions are used, it is important that the cervical spine is kept elevated (pillow) to prevent local anaesthetic spreading to the cervical dermatomes.
Hypotension is more common with spinal anaesthesia than epidural anaesthesia. Patients may benefit from a continuous infusion of pressor agent initiated at the time of insertion of spinal block—see prevention and treatment of hypotension, p. 763.
Continue as for epidural anaesthesia for Caesarean section ( p. 756).
Caesarean section: combined spinal/epidural (CSE)
Advantages . | Disadvantages . |
---|---|
Quick onset Good quality analgesia Intraoperative top-up possible Epidural can be used for postop analgesia | Rapid change in BP and cardiac output Technically more difficult, with higher failure rate of spinal injection Untested epidural catheter |
Advantages . | Disadvantages . |
---|---|
Quick onset Good quality analgesia Intraoperative top-up possible Epidural can be used for postop analgesia | Rapid change in BP and cardiac output Technically more difficult, with higher failure rate of spinal injection Untested epidural catheter |
In some centres CSE has become the technique of choice—indications include:
Prolonged surgery.
Using the epidural catheter for postoperative analgesia.
Limiting the speed of onset of a block. A small initial intrathecal dose of local anaesthetic can be supplemented through the epidural catheter as required.
Technique
History/examination/explanation and consent.
Ensure that antacid prophylaxis has been given.
Establish 16G or larger IV access. Give 10–15ml/kg crystalloid co-load.
The intrathecal injection may be performed by passing the spinal needle through the epidural needle (needle-through-needle technique) or by performing the intrathecal injection completely separately from the epidural placement in either the same or a different interspace. The needle-through-needle technique is associated with an increased incidence of failure to locate CSF with the spinal needle but only involves one injection. If a two-injection technique is used, the epidural is usually sited first because of the time delay that may occur in trying to locate the epidural space with a Tuohy needle after the spinal injection. The risk of damaging the epidural catheter with the spinal needle is theoretical.
With either technique, beware of performing the spinal injection above L3/4, as spinal cord damage has been reported.
Needle-through-needle technique
Either use a dedicated CSE set or locate the epidural space with a Tuohy needle and then pass a long 25G or smaller pencil-point needle through the Tuohy needle into the intrathecal space. Inject anaesthetic solution with the needle orifice pointing cephalad (e.g. 2.5ml 0.5% hyperbaric bupivacaine with 300µg diamorphine or 15µg fentanyl).
Insert epidural catheter. Aspirate the catheter carefully for CSF. Testing the catheter with local anaesthetic before the intrathecal dose has receded may be unreliable. However, using the catheter intraoperatively is reasonable, as the anaesthetist is continuously present to deal with the consequences of an intrathecal injection. This may not be true if opioids are given through the catheter for postoperative analgesia at the end of the procedure before the block has receded.
Two needle technique
Position patient and perform an epidural. After catheter is in position perform a spinal injection at L3/4 or below with a 25G or smaller pencil-point needle.
If the spinal block is inadequate, inject local anaesthetic or 10ml 0.9% sodium chloride through the epidural catheter; 0.9% sodium chloride works by compressing the dural sac, causing cephalad spread of intrathecal local anaesthetic.
Continue as for epidural anaesthesia for Caesarean section ( p. 756).
Special considerations
Although the incidence of major complications of central neuraxial block, as identified by the national audit project of the Royal College of Anaesthetists, was higher when a combined spinal epidural technique was used, the numbers were very small (2 or 4 patients depending on whether an optimistic or pessimistic analysis was used) and the study cautions against overinterpretation of these results.1
Inadequate anaesthesia
Every patient should be warned of the possibility of intraoperative discomfort and this should be documented. Between 1 and 5% of attempted regional anaesthetics for Caesarean section are inadequate for surgery. The majority should be identified before operation commences.
Preoperative inadequate block
Epidural
If no block develops then the catheter is incorrectly positioned. It may be reinserted or a spinal performed.
If a partial but inadequate block has developed, the epidural may be resited or withdrawn slightly. Should the toxic limit for the local anaesthetic agent have been reached, elective procedures can be abandoned, but for urgent procedures a general anaesthetic or a spinal anaesthetic will be required. If a spinal is chosen, exceptional care with positioning and observation of the block level is required, as high or total spinal can occur. Use a normal spinal dose of hyperbaric local anaesthetic, as this should ensure adequate anaesthesia, but control the spread with careful positioning.
Spinal
If no block develops, a repeat spinal may be performed.
If a partial but inadequate block develops, an epidural may be inserted and slowly topped up.
Use a GA if required.
Intraoperative inadequate block
In this situation good communication with the mother and surgeon is essential. If possible, stop surgery. Identify the likely cause of pain (e.g. inadequately blocked sacral nerve roots, peritoneal pain). Try to give the mother a realistic expectation of continued duration and severity of pain. If the pain has occurred before the delivery of the fetus, it is very likely that a GA is required.
If patient requests GA, in all but exceptional circumstances, comply. If the anaesthetist feels that severity of pain is not acceptable, persuade the patient that GA is required.
Spinal
Reassure and treat with:
Inhaled nitrous oxide.
IV opioid (e.g. 25–50µg fentanyl repeated as necessary). Inform the paediatrician that opioid has been given.
Surgical infiltration of local anaesthetic (care with total dose).
GA.
Epidural/CSE
Treat as per spinal anaesthesia, but in addition epidural opioid (e.g. 100µg fentanyl) and/or more epidural local anaesthetic can be used.
Hypotension
Preload
A fluid preload is a traditional part of the anaesthetic technique for regional anaesthesia. It has two functions:
To maintain intravascular volume in a patient who is likely to lose 500–1000ml blood.
To reduce the incidence of hypotension associated with regional anaesthesia.
However, it is questionable how effectively it prevents hypotension. Volumes as large as 30ml/kg or more of crystalloid solution do not reliably prevent hypotension. In some women, particularly those with severe pre-eclampsia, large preloads are harmful as the rise in filling pressures and the reduced colloid osmotic pressure will predispose to pulmonary oedema. The ineffectiveness of preload may in part be due to the rapid redistribution of fluid into the extravascular space. There is evidence that colloids, such as hetastarch, are more effective.
Preload should be:
Timely (given immediately before or during the onset of the regional technique to minimise redistribution).
Limited to 10–15ml/kg crystalloid. Larger volumes should be avoided as they offer little advantage and may be harmful.
More fluid should only be given as clinically indicated.
Colloids are preferred by some anaesthetists if excessive fluid load is likely to be harmful.
Emergency Caesarean section should not be delayed to allow a preload to be administered.
Pressor agents
Ephedrine has been used to treat hypotension in obstetric neuroaxial anaesthesia for many years. However, in the last decade it has been established that treatment to normotension with phenylephrine is associated with marginally better fetal blood gases. However, the difference is marginal. If phenylephrine is used (bolus doses of 50–100 mg) beware of reflex bradycardia which may be profound.
In contrast to fluid preload there is good evidence that using prophyalactic pressor agents is beneficial for both mother and fetus. Various agents have been used, but prophylactic phenylephrine infusion currently appears to be optimal. (A simple regime is to use a syringe driver with a solution of 100mg/ml of phenylephrine (i.e. 10mg in 100ml saline) and start infusing at 30ml/hr as the spinal solution is injected. Titrate to response with increments of 10 ml/hr. Reduce and stop infusing post delivery. Expect heart rate to gradually slow and give anticholinergic agents as required. Avoid this technique in hypertensive individuals.)
Caesarean section: general anaesthesia
Elective general anaesthesia is now uncommon in the UK, limiting opportunities for training. The majority of complications relate to the airway. Failed intubation is much more common in obstetric than non-obstetric anaesthesia (1:250 v. 1:2000 respectively, although more recent reports suggest that this is perhaps an overestimate). All obstetric theatres should have equipment to help with the difficult airway and all obstetric anaesthetists should be familiar with a failed intubation drill.
Indications for general anaesthesia include:
Maternal request.
Urgent surgery. (In experienced hands and with a team that is familiar with rapid regional anaesthesia, a spinal or epidural top-up can be performed as rapidly as a general anaesthetic.)
Regional anaesthesia contraindicated (e.g. coagulopathy, maternal hypovolaemia).
Failed regional anaesthesia.
Additional surgery planned at the same time as Caesarean section.
Technique
Antacid prophylaxis (see p. 766).
Start appropriate monitoring (see below).
Position supine with left lateral tilt or wedge.
Preoxygenate for 3–5min or, in an emergency, with 4–8 vital capacity breaths with a high flow through the circuit. Ensure a seal with the facemask. At term, women have a reduced FRC and a higher respiratory rate and oxygen consumption. This reduces the time required for denitrogenation, but also reduces the time from apnoea to arterial oxygen desaturation.
Perform rapid sequence induction with an adequate dose of induction agent (e.g. 5–7mg/kg thiopental). Isolated forearm techniques suggest that awareness without recall may be common when the dose of induction agent is reduced. A 7.0mm endotracheal tube is adequate for ventilation and may make intubation easier.
Propofol has also been used for Caesarean section without any major reported complications, although at present thiopental probably is still the most commonly used agent in the UK.
Ventilate with 50% oxygen in nitrous oxide. If severe fetal distress is suspected then 75% oxygen or higher may be appropriate. Maintain ETCO2 at 4.0–4.5kPa (30–34 mmHg).
Use ‘overpressure’ of inhalational agent to rapidly increase the end tidal concentration of anaesthetic agent to at least 0.75 of MAC (e.g. 2% isoflurane for 5min, then reduce to 1.5% for a further 5min).
At delivery:
Give 5IU oxytocin IV bolus. If tachycardia must be avoided then an IV infusion of 30–50IU syntocinon in 500ml crystalloid, infused over 4hr, is effective.
Administer opioid (e.g. 10–15mg morphine).
Ventilate with 35% inspired oxygen concentration in nitrous oxide. Inhalational agent can be reduced to 0.75 MAC to reduce uterine relaxation.
Extubate awake in the head-down left lateral position.
Give additional IV analgesia as required.
Effect of general anaesthesia on the fetus
Most anaesthetic agents, except for the muscle relaxants, rapidly cross the placenta. Thiopental can be detected in the fetus within 30s of administration, with peak umbilical vein concentration occurring around 1min. Umbilical artery to umbilical vein concentrations approach unity at 8min. Opioids administered before delivery may cause fetal depression. Although rarely required, neonatal respiratory depression can be rapidly reversed with naloxone (e.g. 200µg IM or 10µg/kg IV). If there is a specific indication for opioids before delivery they should be given and the paediatrician informed. Hypotension, hypoxia, hypocapnia, and excessive maternal catecholamine secretion may all be harmful to the fetus.
Failed intubation
When intubation fails but mask ventilation succeeds, a decision on whether to continue with the Caesarean section must be made. A suggested grading system is1:
Grade 1: Mother's life dependent on surgery.
Grade 2: Regional anaesthetic unsuitable (e.g. coagulopathy/ haemorrhage).
Grade 3: Severe fetal distress (e.g. prolapsed cord).
Grade 4: Varying severity of fetal distress with recovery.
Grade 5: Elective procedure.
For Grade 1 cases surgery should continue, and for Grade 5 the mother should be woken. The action between these extremes must take account of additional factors including the ease of maintaining the airway, the likely difficulty of performing a regional anaesthetic, and the experience of the anaesthetist. Once a failed intubation has occurred and an airway has been established, reapply fetal monitoring as this may give useful additional information to guide management.
Antacid prophylaxis
Aspiration of particulate matter or bile is associated with worse outcome than aspiration of gastric fluid. Fluid aspiration is commonly associated with a chemical pneumonitis and the severity of this is in turn dependent on the volume and acidity of the aspirated fluid. Use of antacids and prokinetic agents can elevate the gastric pH and reduce the intragastric volume. A suggested regime is:
Elective surgery
150mg ranitidine orally 2hr and 12hr before surgery.
10mg metoclopramide orally 2hr before surgery.
30ml 0.3M sodium citrate immediately before surgery. (Gastric pH >2.5 is maintained for only 30min after 30ml 0.3M sodium citrate. If a GA is required after this, a further dose of citrate is required.)
Emergency surgery (if prophylaxis has not already been given)
50mg ranitidine by slow IV injection immediately before surgery. (Proton pump inhibitors are an alternative.)
10mg metoclopramide IV injection immediately before surgery.
30ml 0.3M sodium citrate orally immediately before surgery.
Postoperative analgesia
Most post partum women are very well motivated and mobilise quickly. However, effective analgesia does allow earlier mobilisation. The mainstays of postoperative analgesia are opioids, NSAIDs, and paracetamol. The route that these are given is dependent on the intraoperative anaesthetic technique.
Opioids
IV patient-controlled analgesia or oral opioid can be used, although these are not as effective as neuraxial analgesia. A small quantity of opioid may be transferred to the neonate through breast milk, but with negligible effect.
Intrathecal/epidural opioid:
When given as a bolus at the beginning of surgery, fentanyl lasts little longer than the local anaesthetic and provides almost no postoperative analgesia. Epidural fentanyl may be given as an infusion or as intermittent postoperative boluses (50–100µg up to 2-hourly for 2 or 3 doses) if the epidural catheter is left in situ.
Intrathecal diamorphine (300µg) can be expected to provide 6–18hr of analgesia. More than 40% of women will require no other postoperative opioid. Higher doses have been recommended but are associated with an increased incidence of side effects. Pruritus is very common (60–80% of cases), although only 1–2% have severe pruritus. This can be treated with 20–200µg naloxone IM.
Epidural diamorphine (2.5mg in 10ml saline) provides 6–10hr of analgesia after a single dose. Intermittent doses may be given if the epidural catheter is left in situ.
Intrathecal preservative-free morphine (100µg) provides long- lasting analgesia (12–18hr). Doses above 150µg are associated with increased side effects without improved analgesia. However, pruritus and nausea are common. The low lipophilicity of morphine may increase risk of late respiratory depression. Epidural morphine (2–3mg) provides analgesia for 6–24 hr, but pruritus is again common and nausea occurs in 20–40% of cases. Diamorphine is used much more commonly in the UK than morphine. Preservative-free pethidine may also be used (10–50mg epidurally).
NSAIDs
NSAIDs are very effective postoperative analgesics, reducing opioid requirements. They should be administered regularly whenever possible, but beware renal impairment in severe pre-eclampsia.
Retained placenta
Check IV access with 16G or larger cannula has been obtained.
Assess total amount and rate of blood loss and cardiovascular stability. Blood loss may be difficult to accurately assess. If rapid blood loss is continuing then urgent crossmatch and evacuation of placenta under general anaesthetic is required.
Regional anaesthesia is safe provided estimated blood loss is less than 1000ml, but if there are any signs suggesting hypovolaemia, a general anaesthetic may be required.
Remember antacid prophylaxis.
For general anaesthesia use a rapid sequence induction technique with cuffed ETT.
Regional anaesthesia can be obtained either by topping up an existing epidural or by performing a spinal (e.g. 2ml 0.5% hyperbaric bupivacaine intrathecally). A T7 block reliably ensures analgesia.1
Occasionally uterine relaxation is required. Under general anaesthesia this can be produced by increasing the halogenated vapour concentration. Under regional anaesthesia SL GTN spray or IV aliquots of 100µg glyceryl trinitrate are effective (dilute 1mg in 10ml 0.9% sodium chloride and give 1ml bolus repeated as required). With either technique expect transient hypotension.
On delivery of the placenta give 5IU oxytocin ± an infusion of oxytocin (e.g. 30–50IU in 500ml crystalloid over 4hr).
At the end of the procedure give an NSAID unless contraindicated.
Procedure . | Technique . | Suggested dose . |
---|---|---|
Labour | Epidural loading dose | 20ml 0.1% bupivacaine with 2µg/ml fentanyl |
Epidural infusion | 10ml/hr 0.1% bupivacaine with 2µg/ml fentanyl | |
Top-ups | 10–20ml 0.1% bupivacaine with 2µg/ml fentanyl | |
CSE | Intrathecal: 1ml 0.25% bupivacaine with 5–25µg/ml fentanyl | |
Epidural: top-up and infusion as above | ||
PCEA | 5ml boluses of 0.1% bupivacaine with 2µg/ml fentanyl with a 10–15min lockout | |
LSCS | Spinal | 2.5ml 0.5% bupivacaine in 8% glucose (‘heavy’) + 300µg diamorphine |
Epidural | 15–20ml 2% lidocaine with 1:200 000 adrenaline (1ml of 1:10 000 added to 19ml solution) | |
CSE | Normal spinal dose (reduce if slow onset of block is required) | |
If needed, top-up the epidural with 5ml aliquots of 2% lidocaine with 1:200 000 adrenaline | ||
Post LSCS analgesia | GA | Bilateral ilioinguinal nerve blocks or TAP blocks at end of surgery |
IV aliquots of morphine until comfortable | ||
Parenteral opioid (oral or PCA as available) | ||
GA and regional | 100mg diclofenac PR at end of surgery, followed by 75mg diclofenac PO 12-hourly | |
Simple analgesics as required (i.e. co-codamol, co-dydramol, etc.) | ||
Regional | Epidural diamorphine (2.5mg) in 10ml 0.9% sodium chloride 4-hourly prn |
Procedure . | Technique . | Suggested dose . |
---|---|---|
Labour | Epidural loading dose | 20ml 0.1% bupivacaine with 2µg/ml fentanyl |
Epidural infusion | 10ml/hr 0.1% bupivacaine with 2µg/ml fentanyl | |
Top-ups | 10–20ml 0.1% bupivacaine with 2µg/ml fentanyl | |
CSE | Intrathecal: 1ml 0.25% bupivacaine with 5–25µg/ml fentanyl | |
Epidural: top-up and infusion as above | ||
PCEA | 5ml boluses of 0.1% bupivacaine with 2µg/ml fentanyl with a 10–15min lockout | |
LSCS | Spinal | 2.5ml 0.5% bupivacaine in 8% glucose (‘heavy’) + 300µg diamorphine |
Epidural | 15–20ml 2% lidocaine with 1:200 000 adrenaline (1ml of 1:10 000 added to 19ml solution) | |
CSE | Normal spinal dose (reduce if slow onset of block is required) | |
If needed, top-up the epidural with 5ml aliquots of 2% lidocaine with 1:200 000 adrenaline | ||
Post LSCS analgesia | GA | Bilateral ilioinguinal nerve blocks or TAP blocks at end of surgery |
IV aliquots of morphine until comfortable | ||
Parenteral opioid (oral or PCA as available) | ||
GA and regional | 100mg diclofenac PR at end of surgery, followed by 75mg diclofenac PO 12-hourly | |
Simple analgesics as required (i.e. co-codamol, co-dydramol, etc.) | ||
Regional | Epidural diamorphine (2.5mg) in 10ml 0.9% sodium chloride 4-hourly prn |
LSCS = lower segment Caesarean section
Breast feeding and drug transfer
If a drug is to be transferred from mother to neonate through breast feeding, it must be secreted in the milk, absorbed in the neonatal gastrointestinal tract and not undergo extensive first pass metabolism in the neonatal liver. In general, for breast-fed infants, the neonatal serum concentration of a drug is less than 2% of maternal serum concentration, resulting in a sub-therapeutic dose. Most drugs are therefore safe. However, there are some exceptions to this rule—either because transfer is much higher or because transfer of even minute quantities of a drug is unacceptable. Drugs with high protein binding may displace bilirubin and precipitate kernicterus in a jaundiced neonate.
Factors that make significant transfer more likely include:
Low maternal protein binding.
Lipophilicity or, with hydrophilic drugs, a molecular weight of <200Da.
Weak bases (which increase the proportion of ionised drug in the weakly acidic breast milk, leading to ‘trapping’).
Transfer to the neonate can be minimised by breast feeding before administering the drug, and if the neonate has a consistent sleep period, administering the drug to mother at the beginning of this.
Although many drugs are excreted in minimal quantities in breast milk with no reports of ill effects, manufacturers will often recommend avoiding agents during breast feeding.
Co-codamol and breast feeding
In breast-fed neonates, regular maternal co-codamol use has been associated with neonatal respiratory depression. Co-codamol should only be used in supervised surroundings and discontinued if mother or neonate becomes drowsy.
Remember, breast feeding constitutes a metabolic and fluid load for the mother, so if surgery is contemplated then keep the mother well hydrated, and if the surgery is elective, have the patient first on the list. Try to minimise nausea and vomiting.
The following table gives information on some agents; a full list of drug compatibility with breast feeding is beyond the scope of this book.
Drug . | Comment . |
---|---|
Opioids | Minimal amount delivered to neonatal serum. Minor concern about the long duration of action of pethidine's metabolite, nor-pethidine. Care with co-codamol |
NSAIDs | Most NSAIDs are considered safe in breast feeding. Some would advise caution with aspirin because of unsubstantiated concerns about causing Reye's syndrome in the neonate |
Antibiotics | Penicillins and cephalosporins are safe, although trace amounts may be passed to the neonate |
Tetracycline should be avoided (although absorption is probably minimal because of chelation with calcium in the milk) | |
Chloramphenicol may cause bone-marrow suppression in the neonate and should be avoided | |
Ciprofloxacin is present in high concentrations in breast milk and should be avoided | |
Antipsychotics | Generally suggested that these should be avoided although the amount excreted in milk is probably too small to be harmful. Chlorpromazine and clozapine cause neonate drowsiness |
Cardiac drugs | Amiodarone is present in milk in significant amounts and breast feeding should be discontinued |
Most β-blockers are secreted in minimal amounts. Sotalol is present in larger amounts. Avoid celiprolol | |
Anticonvulsants | While carbamazepine does not accumulate in the neonate, phenobarbital and diazepam may. Neonates should be observed for evidence of sedaion |
Drug . | Comment . |
---|---|
Opioids | Minimal amount delivered to neonatal serum. Minor concern about the long duration of action of pethidine's metabolite, nor-pethidine. Care with co-codamol |
NSAIDs | Most NSAIDs are considered safe in breast feeding. Some would advise caution with aspirin because of unsubstantiated concerns about causing Reye's syndrome in the neonate |
Antibiotics | Penicillins and cephalosporins are safe, although trace amounts may be passed to the neonate |
Tetracycline should be avoided (although absorption is probably minimal because of chelation with calcium in the milk) | |
Chloramphenicol may cause bone-marrow suppression in the neonate and should be avoided | |
Ciprofloxacin is present in high concentrations in breast milk and should be avoided | |
Antipsychotics | Generally suggested that these should be avoided although the amount excreted in milk is probably too small to be harmful. Chlorpromazine and clozapine cause neonate drowsiness |
Cardiac drugs | Amiodarone is present in milk in significant amounts and breast feeding should be discontinued |
Most β-blockers are secreted in minimal amounts. Sotalol is present in larger amounts. Avoid celiprolol | |
Anticonvulsants | While carbamazepine does not accumulate in the neonate, phenobarbital and diazepam may. Neonates should be observed for evidence of sedaion |
Placenta praevia and accreta
Placenta praevia
Placenta praevia occurs when the placenta implants between the fetus and the cervical os. The incidence is about 1 in 200 pregnancies but is higher with previous uterine scars and multiparity.
Three questions can be used to evaluate the anaesthetic implications of a placenta praevia:
Is a vaginal delivery possible? (Unlikely if the placenta extends to within 2cm of the os.)
If not, does the placenta cover the anterior lower segment of the uterus. (If it does, the obstetrician will have to divide the placenta to deliver the fetus and blood loss can be expected to be large.)
Is there a uterine scar from previous surgery? (Placenta accreta is more common if the placenta overlies a uterine scar.)
Diagnosis is usually made by ultrasound. Obstetric management is aimed at preserving the pregnancy until the 37th gestational week. Premature labour, excessive bleeding, or fetal distress may necessitate delivery. If at 37wk gestation a vaginal delivery is not possible, a Caesarean section is performed.
Placenta accreta
Placenta accreta occurs with abnormal implantation of the placenta. Usually the endometrium produces a cleavage plane between the placenta and the myometrium. In placenta accreta vera the placenta grows through the endometrium to the myometrium. In placenta increta the placenta grows into the myometrium, and in placenta percreta the placenta grows through the myometrium to the uterine serosa and on into surrounding structures. Because the normal cleavage plane is absent, following delivery the placenta fails to separate from the uterus, which can result in life-threatening haemorrhage.
Incidence is rising, possibly as a result of the increasing numbers of Caesarean sections performed. Placenta accreta is much more common when the placenta implants over a previous scar. A woman who has had two previous sections and a placenta that has implanted over the uterine scar has a 50% chance of developing a placenta accreta and two-thirds of these cases will require Caesarean hysterectomy. Diagnosis of percreta can be made with ultrasound ± MRI scan or the presence of haematuria. However, placenta accreta and increta are often diagnosed at surgery.
Anaesthetic management
Anaesthetic management is dictated by the likelihood of major haemorrhage, maternal preference, and the obstetric/anaesthetic experience levels. Patients with placenta praevia are at risk of haemorrhage because:
Placenta may have to be divided to facilitate delivery.
Lower uterine segment does not contract as effectively as the body of the uterus so the placental bed may continue to bleed following delivery.
Further increase in risk occurs sequentially with placenta accreta, increta, and percreta. Caesarean hysterectomy is required in 95% of women with placenta percreta with a 7% overall mortality rate.
Although the sympathectomy that occurs with regional anaesthesia may make control of blood pressure more difficult, practical experience shows that regional anaesthesia can be safely used for placenta praevia, providing the patient is normovolaemic before the neuraxial technique is performed. Even in Caesarean hysterectomy, the degree of hypotension and blood loss is the same with regional and general anaesthetic techniques. However, if significant haemorrhage does occur, hypotensive and bleeding patients will require reassurance and this may divert the anaesthetist from providing volume resuscitation. Regional anaesthesia should therefore only be undertaken by experienced anaesthetists with additional help available.
Technique
Experienced obstetricians and anaesthetists are essential.
All patients admitted with placenta praevia should be seen and assessed by an anaesthetist.
When Caesarean section is to be performed 2–8U of blood should be crossmatched, depending on the anticipated risk of haemorrhage.
Cell salvage should be used if available. In obstetric practice, to reduce the fetal tissue that is reinfused, efforts should be made to minimise the amount of amniotic fluid that is collected and, after processing, the red cells should be reinfused through a leucocyte depletion filter.
Obstetric staff experienced in Caesarean hysterectomy should be immediately available.
Two 14G cannulae should be inserted and equipment for massive haemorrhage must be present.
If regional anaesthesia is used, a CSE may offer advantages as the surgery may be prolonged.
For bleeding patients a general anaesthetic is the preferred choice.
Have a selection of uterotonics to hand (see p. 776). Even if massive haemorrhage is not encountered, an infusion is advantageous (e.g. oxytocin 30–50IU in 500ml crystalloid over 1–2hr).
If massive bleeding does occur, hysterectomy may be the only method of controlling bleeding. Excessive delay in making this decision may jeopardise maternal life (see also p. 774).
Do not forget surgical methods of controlling haemorrhage—bimanual compression of the uterus, ligation of internal iliac arteries, temporary compression of the aorta.
Even if no significant bleeding occurred intraoperatively, continue to observe closely in the postnatal period as haemorrhage may still occur.
Massive obstetric haemorrhage
The gravid uterus receives 12% of the cardiac output and when haemorrhage occurs it can be extremely rapid. In the developing world, haemorrhage is the leading cause of maternal death. Placental abruption, postpartum haemorrhage, and placenta praevia are the principal causes of massive haemorrhage.
The fetus is at greater risk from maternal haemorrhage than the mother. Hypotension reduces uteroplacental blood flow and severe anaemia will further reduce oxygen delivery. In addition abruption may directly compromise blood supply. Fetal mortality may be as high as 35%. Standard protocols for major haemorrhage should be available in every delivery suite.
Aetiology of obstetric haemorrhage
Antenatal
Placental abruption. Bleeding is often associated with pain. Blood loss may be concealed with retroplacental bleed. Fetal compromise is common. Small bleeds may be treated conservatively.
Placenta praevia/accreta. Usually a small painless bleed. May be catastrophic.
Uterine rupture. Fetal distress is almost universal. Classically uterine rupture is said to be painful, but painless dehiscence of a previous uterine scar is not uncommon.
Postnatal
Defined as blood loss of greater than 500ml post delivery. Estimates of ‘normal’ blood loss after vaginal delivery are of the order of 250–400ml and after Caesarean section around 500–1000ml. Blood loss is usually underestimated.
Uterine atony. Associated with chorioamnionitis, prolonged labour, and an abnormally distended uterus (e.g. polyhydramnios, macrosomia, multiple gestation).
Retained placenta. Haemorrhage may be massive but is usually less than 1 litre and occasionally minimal.
Retained products of conception. This is the leading cause of late haemorrhage but is rarely massive.
Genital tract trauma. Vaginal and vulval haematomas are usually self-limiting, but retroperitoneal haematomas may be extensive and life threatening.
Uterine inversion. This is a rare complication in the Western world. It is associated with uterine atony and further relaxation may be required to enable replacement. After replacement uterotonics should be administered.
Diagnosis
Diagnosis of haemorrhage is usually self-evident, although be aware that concealed bleeding may occur, especially with placental abruptions. In addition signs of cardiovascular decompensation may be delayed, as women are usually young and fit and start with a pregnancy-induced expansion of their intravascular volume. Beware of the woman with cold peripheries—this is abnormal in pregnancy. Hypotension is a late and worrying sign.
Management
In the event of a major haemorrhage requiring surgery, do not delay operation until crossmatched blood is available.
Call for help.
Give supplemental oxygen. If laryngeal reflexes are obtunded, intubate and ventilate. In antenatal patients avoid aortocaval compression.
Insert two 14G cannulae and take blood for crossmatching. Request type-specific blood (this can be retrospectively crossmatched).
Fluid resuscitate with crystalloid and/or colloid.
If required give Group O Rhesus negative blood (i.e. blood loss of 2–3 litres and ongoing without the imminent prospect of crossmatched blood being available and/or the presence of ECG abnormalities).
Start appropriate monitoring of mother and fetus. Urine output and invasive monitoring of central venous and arterial pressures may be indicated depending on rate of blood loss and maternal condition. However, early monitoring of CVP is not essential as hypotension is almost always due to hypovolaemia.
Treat the cause of haemorrhage. If surgery is required:
Do not perform a regional technique if the patient is hypovolaemic.
Beware of coagulopathies in the presence of concealed abruption.
With continuing haemorrhage further equipment including warming devices and rapid transfusion devices should be available.
Correct coagulopathy with platelets, fresh frozen plasma, and cryoprecipitate as indicated.
Once blood loss has been controlled, continue care on HDU or ICU.
Specific treatment for haemorrhage
Treatment may be with uterotonics or surgery or both, depending on the cause:
Uterotonics can only be used in the postnatal period.
Most postnatal haemorrhage is due to uterine atony and can be temporarily controlled with firm bimanual pressure while waiting for definitive treatment.
Interventional radiology is especially useful when major haemorrhage is anticipated. It may not reduce the incidence of Caesarean hysterectomy but probably reduces blood loss. Balloon catherters can be prophylactically placed in the internal illiac vessels before delivery (but only inflated at the moment of delivery!). However, interventional radiology can also be used in response to a major bleed, but be very cautious of moving a patient to a radiology suite if they are cardiovascularly unstable. Intrauterine tamponade with Bakri or Sengstaken catheters left in situ for 24hr can also be useful.
Drug . | Dose . | Comment . |
---|---|---|
Oxytocin (Syntocinon®) | 5IU bolus 30–50IU in 500ml crystalloid and titrated as indicated | Synthetically produced hormone causing uterine contraction and peripheral vasodilation and has very mild antidiuretic hormone actions. Early preparations made from animal extracts had significant ADH activity |
Ergometrine | 0.5mg IM or 0.125mg by slow IV injection and repeat to a total of 0.5mg | An ergot alkaloid derivative. Produces effective uterine constriction, but nausea and vomiting are very common. Systemic vasoconstriction may produce dangerous hypertension in at-risk groups (e.g. pre-eclampsia, specific cardiac disease) |
Carboprost (Hemabate®) (15-methyl prostaglandin F2α) | 0.25mg intramyometrially or IM every 10–15min to a max of 2mg | Effective uterine constrictor. Also causes nausea, vomiting, and diarrhoea. May produce severe bronchospasm, alter pulmonary shunt fraction, and induce hypoxia (caution in asthmatics) |
Misoprostol | 1mg PR | Effective uterine constrictor. As with carboprost can also cause nausea, vomiting, and diarrhoea. May also cause bronchospasm and alter shunt fraction, but not usually as severe as with carboprost |
Drug . | Dose . | Comment . |
---|---|---|
Oxytocin (Syntocinon®) | 5IU bolus 30–50IU in 500ml crystalloid and titrated as indicated | Synthetically produced hormone causing uterine contraction and peripheral vasodilation and has very mild antidiuretic hormone actions. Early preparations made from animal extracts had significant ADH activity |
Ergometrine | 0.5mg IM or 0.125mg by slow IV injection and repeat to a total of 0.5mg | An ergot alkaloid derivative. Produces effective uterine constriction, but nausea and vomiting are very common. Systemic vasoconstriction may produce dangerous hypertension in at-risk groups (e.g. pre-eclampsia, specific cardiac disease) |
Carboprost (Hemabate®) (15-methyl prostaglandin F2α) | 0.25mg intramyometrially or IM every 10–15min to a max of 2mg | Effective uterine constrictor. Also causes nausea, vomiting, and diarrhoea. May produce severe bronchospasm, alter pulmonary shunt fraction, and induce hypoxia (caution in asthmatics) |
Misoprostol | 1mg PR | Effective uterine constrictor. As with carboprost can also cause nausea, vomiting, and diarrhoea. May also cause bronchospasm and alter shunt fraction, but not usually as severe as with carboprost |
Amniotic fluid embolism
Amniotic fluid embolism (AFE) is the fourth most common direct cause of maternal death in the UK (CEMACH 2003–051).
Incidence: ∼1:12 000 live births.2
Effects are probably due to an anaphylactic response to fetal tissue.
Within the first 30min after amniotic fluid embolism, intense pulmonary vasoconstriction occurs and is associated with right heart failure, hypoxia, hypercarbia, and acidosis.
This is followed by left heart failure and pulmonary oedema.
Expect a coagulopathy.
Incidence of AFE is increased with:
Age >25yr.
Multiparous women.
Obstructed labour, particularly in association with uterine stimulants.
Multiple pregnancy.
Short labours.
AFE is often a diagnosis of exclusion, but clinical features include:
Sudden collapse with acute hypotension and fetal distress.
Pulmonary oedema (>90% of cases) and cyanosis (80%).
Coagulopathy (80%). Haemorrhage may be concealed.
Fits (50%).
Cardiac arrest (occurs in nearly 90% of women).
Little advance has been made in treating this devastating condition, although care with the use of uterine stimulants and timely diagnosis of obstructed labour may help to reduce the incidence.
Once AFE has occurred, treatment is purely supportive:
Airway, breathing, and circulation.
Senior staff should be present (obstetric, anaesthetic, paediatric, and midwifery).
Haematology services should be alerted, as large quantities of blood products may be required.
Early delivery of the fetus is vital for both maternal and fetal survival.
Measure coagulation profile regularly. Platelets fresh frozen plasma, and cryoprecipitate may all be required.
Intensive care will be required for those who survive the initial insult.
Early mortality is high (50% within the first hour). Even in those who survive, long-term neurological problems are common.
Cardiac disease and pregnancy
Cardiac disease is the leading cause of indirect maternal death in pregnancy. Ischaemic heart disease remains the most common cause of maternal cardiac death in the UK, but with the increased survival into child-bearing years of the previous generation of patients with complex congenital cardiac malformations, and the movement of populations across the world, the incidence of complex structural cardiac lesions is increasing. Obesity and increasing maternal age are also significantly associated with an increased incidence of cardiac disease.
Pregnancy and labour often present a severe stress test to these women. As a generality, if a woman was symptomatic with minimal activity before pregnancy, particularly if symptomatic at rest (New York Heart Association Classification III and IV), the course of pregnancy is likely to be stormy and mortality of the order of 20–30% is to be expected. The period of greatest stress is in the immediate post partum period.
It is beyond the scope of this book to give anything but the broadest plans of how to manage women with cardiac disease during pregnancy:
It is vital to have an early assessment and involve a multidisplinary team consisting of a combination of obstetricians, anaesthetists, cardiologists, midwives, and neonatologists.
Plan the delivery. There is little evidence that vaginal delivery is associated with a worse outcome for many cardiac patients. However, on occasions, an elective Caesarean section may offer advantage as appropriate personnel can be guaranteed to be present.
Investigations should be performed as indicated. The risk to the fetus from procedures such as chest radiographs is minimal.
Make sure that the woman is in an appropriate place for delivery (this may be the normal delivery suite or it may be the cardiac theatres in a tertiary centre).
With each condition, in consultation with the cardiologists, consider the effects of vasodilation, vasoconstriction, and positive and negative inotropic and chronotropic agents. This will help with the planning of the delivery, and can allow written guidance on the likely acceptability of regional analgesia and regional or general anaesthesia, as well as the use of oxytocin (potent vasodilator) and ergometrine. It can also allow planning of the appropriate agent to use in the event of hypotension.
Some centres use a form where all these elements of the anaesthetic management of complex patients are specified. The form remains with the mother throughout her pregnancy.
In most situations rapid changes in pre- or afterload should be avoided, so always use oxytocin with extreme caution and preferably only as an infusion.
Expect the period of highest risk to be in the 1–2hr post delivery (cardiac output peaks and autotransfusion plus blood loss leads to a variable effect on pre- and afterload).
Continue management on ICU if appropriate.
General principles
Conditions associated with pulmonary hypertension have a very high maternal mortality in pregnancy (>70%).
Extreme caution is required to avoid sudden changes in afterload for patients with fixed cardiac output.
Cyanotic heart lesions (i.e. right-to-left shunts) will not tolerate reductions in systemic vascular resistance. Nevertheless epidural analgesia is sometimes used to minimise the stress of labour, but onset of analgesia must be slow, and use phenylephrine to maintain afterload. General anaesthesia is probably the technique of choice for Caesarean section.
Aortic stenosis may become symptomatic during pregnancy. Serial echocardiography is often used. Tachycardia and reduction in afterload should be avoided. Loss of sinus rhythm should be treated promptly. General or slow-onset regional anaesthesia have both been advocated for Caesarean section. The technique is probably less important than the skill with which it is applied.
Valvular insufficiencies are usually well tolerated during pregnancy.
Myocardial infarction during pregnancy has a 20% mortality. Infarction occurs most commonly in the third trimester. If possible, delivery should be delayed at least 3wk after infarction. Both elective Caesarean section and vaginal delivery have been advocated. In either case, cardiac stress should be minimised with effective analgesia.
Maternal resuscitation
After 20wk gestation, the mother must be tilted to minimise aortocaval compression. The tilt is ideally provided by a wooden wedge, but if this is not available an assistant can kneel beside the arrested individual and the hips wedged on to the knees of the assistant.
After 20wk gestation the fetus should be delivered as soon as possible. This improves the chance of maternal survival (and that of a term fetus) as aortocaval compression severely limits the effectiveness of chest compressions. The fetus is likely to be severely acidotic and hypoxic at delivery.
Remember that pregnant women have reduced oesophageal sphincter tone and that cricoid pressure and intubation should both be performed as rapidly as possible.
Normal resuscitation drugs should be used. Adrenaline is the drug of choice despite its effect on uterine circulation.
Adrenaline is also the drug of choice in major anaphylactic and anaphylactoid reactions. Severe hypotension associated with anaphylaxis results in very poor fetal outcome. Early delivery is vital for the fetus.
Consideration should be given to the diagnosis and treatment of obstetric causes of maternal arrest.
Common causes of maternal arrest include:
Haemorrhage.
Pulmonary embolism.
Amniotic fluid embolus.
Intracranial haemorrhage.
Myocardial infarction.
Iatrogenic events:
Hypermagnesaemia—treat with 10ml of 10% calcium chloride.
High or total spinal—supportive treatment.
Local anaesthetic-induced arrhythmia—treat with intralipid® (see p. 1182).
Pre-eclampsia remains a leading cause of maternal death. It is a systemic disorder and the precise aetiology is complex and incompletely understood. Immunological factors, genetic factors, endothelial dysfunction, as well as abnormalities in placental implantation, fatty acid metabolism, coagulation, and platelet factors have all been implicated. The earlier in gestation that pre-eclampsia manifests itself, the more severe the disease.
Definitions
Hypertension: a sustained systolic BP >140mmHg or diastolic BP >90mmHg.
Chronic hypertension: hypertension that existed before pregnancy.
Pregnancy-induced hypertension: hypertension that develops in pregnancy. In the absence of other signs of pre-eclampsia, this has minimal effect on pregnancy but may be indicative of a tendency to hypertension in later life.
Pre-eclampsia: pregnancy-induced hypertension in association with renal involvement causing proteinuria (>300mg/24hr or 2+ on urine dipstick). Incidence 6–8% of all gestations.
Severe pre-eclampsia: pre-eclampsia in association with any of the following: a sustained BP >160/110; proteinuria >5g/24hr or 3+ on urine dipstick; urine output <400ml/24hr; pulmonary oedema or evidence of respiratory compromise; epigastric or right upper quadrant pain; hepatic rupture, platelet count <100 × 109/l; evidence of cerebral complications. Incidence is 0.25–0.5% of all gestations.
Eclampsia: convulsions occurring in pregnancy or puerperium in the absence of other causes. Almost always occurs in the presence of pre-eclampsia, although signs of pre-eclampsia may not be manifest until after a fit.
Pathophysiology
Cardiorespiratory
Hypertension and increased sensitivity to catecholamine and exogenous vasopressors.
Reduced circulating volume but increased total body water.
In severe pre-eclampsia systemic vascular resistance is increased and cardiac output reduced. However, some women have elevated cardiac output with normal or only marginally increased systemic vascular resistance. Fetal prognosis is improved in this group.
Poor correlation between central venous and pulmonary capillary wedge pressure.
Increased capillary permeability which may result in:
Pulmonary oedema. Be very careful to avoid fluid overload.
Laryngeal and pharyngeal oedema. Stridor may result.
Haematological
Reduced platelet count with increased platelet consumption and hypercoagulability with increased fibrin activation and breakdown. Disseminated intravascular coagulation may result.
Increased haematocrit resulting from decreased circulating volume.
Renal function
A reduced glomerular filtration rate.
Increased permeability to large molecules resulting in proteinuria.
Decreased urate clearance with rising serum uric acid level.
Oliguria in severe disease.
Cerebral function
Headache, visual disturbance, and generalised hyperreflexia.
Cerebrovascular haemorrhage.
Eclampsia (resulting from cerebral oedema or cerebrovascular vasoconstriction).
Fetoplacental unit
Reduced fetal growth with associated oligohydramnios.
Poor placental perfusion and increased sensitivity to changes in maternal BP.
Reduction of umbilical arterial diastolic blood flow and particularly reverse diastolic flow are indicative of poor fetal outcome without early intervention.
Management of pre-eclampsia
There is no effective prophylactic treatment to prevent pre-eclampsia. Some obstetricians may use low-dose aspirin in selected high-risk pregnancies, but benefit is marginal.
In established pre-eclampsia the only definitive treatment is the delivery of the placenta. Symptoms will usually start to resolve within 24–48hr.
When pre-eclampsia develops at term there is no advantage to delaying delivery. However, if pre-eclampsia develops before term, a compromise has to be made between maternal and fetal health. Maternal blood pressure is controlled for as long as possible to allow fetal growth to be optimised. If fetal or maternal condition deteriorates, delivery must be expedited.
Antihypertensive therapy. Blood pressure should be controlled to below 160/110 to prevent maternal morbidity particularly from intracranial haemorrhage, encephalopathy, and myocardial ischaemia/failure.
Established oral antihypertensive drugs include oral methyldopa/nifedipine preparations and β-blockers (particularly the combined α- and β -blocker labetalol). Prolonged use of β-blockers may reduce fetal growth.
ACE inhibitors are associated with oligohydramnios, still birth, and neonatal renal failure. They should be avoided.
Rapid control of severe hypertension can be achieved with:
Hydralazine (5mg IV aliquots to a maximum of 20mg).
Labetalol (5–10mg IV every 10min).
Oral nifedipine. (10mg). SL nifedipine should be avoided because of associated rapid changes in placental circulation which may compromise fetal condition.
In very rare cases infusions of glyceryl trinitrate may be needed. If used, invasive arterial pressure monitoring is required.
Magnesium prophylaxis in pre-eclampsia effectively reduces the incidence of eclampsia, but increases the frequency with which the side effects of magnesium therapy are seen. Severe pre-eclamptic patients are usually treated with magnesium.
Fluid management in severe pre-eclampsia is critical. Intravascular volume is depleted, but total body water is increased. Excessive fluid load may result in pulmonary oedema, but underfilling may compromise fetal circulation and renal function. General principles are:
Individual units are encouraged to develop and follow a fluid management protocol.
A named individual should have overall responsibility for fluid therapy in a patient with severe pre-eclampsia.
Measure hourly urine output.
Beware of excessive fluid loads being delivered with drug therapy (i.e. oxytocin or magnesium). Increased concentrations may be required.
Be cautious with preload before Caesarean section and avoid preload before regional analgesia.
A common approach is to use a small background infusion of crystalloid, and to treat persistent oliguria with 250–500ml of colloid. If oliguria continues, further fluid management is usually guided by central venous pressure.
Invasive arterial pressure monitoring is indicated in severe pre-eclampsia for:
Monitoring the response to laryngoscopy and surgery during general anaesthesia.
Taking repeated arterial blood gases.
Monitoring rapidly acting hypotensive agents.
Central venous pressure monitoring is rarely indicated even in severe pre-eclampsia as central venous pressure may not correlate well with pulmonary arterial wedge pressure. It should be considered:
For persistent oliguria (<0.5ml/kg/hr) unresponsive to small fluid challenges.
If pulmonary oedema develops.
Analgesia for vaginal delivery
Effective epidural analgesia controls excessive surges in blood pressure during labour and is recommended.
Check platelet count before performing an epidural. If maternal condition is rapidly deteriorating or if the platelet numbers are falling then a count must be performed immediately before placement. The ‘acceptable’ level of platelet count is debatable and based on little evidence. However, common general guidelines are:
If the platelet count is <100 × 109/l, a clotting screen is required.
If the platelet count is >80 × 109/l and the clotting screen is normal then regional techniques are acceptable.
With a platelet count of <80 × 109/l, a very careful assessment from a senior individual is required and the potential risks and benefits should be discussed with the patient.
Thromboelastography may offer a better method of assessing bleeding potential, but as yet its place is unproven.
Preload before regional analgesia is not required, but monitor BP and fetus carefully and treat changes in BP promptly with cautious doses of ephedrine or phenylephrine (IV infusions may be preferable).
Anaesthesia for Caesarean section
General anaesthesia or regional anaesthesia may be used. General anaesthesia is indicated if significant thrombocytopenia (see above) or coagulopathy has developed.
General anaesthesia
Assess the airway carefully. Sometimes partners may be better able to assess onset of facial oedema. A history of stridor is of major concern. A selection of small tube sizes must be available. Consider awake fibreoptic intubation in severe cases.
Obtund the hypertensive response to laryngoscopy, e.g. alfentanil 1–2mg (inform paediatrician that opioids have been used) or labetalol 10–20mg before induction. A remifentanil infusion may be useful if the anaesthetist is familiar with its use. In very severe pre-eclampsia, intra-arterial pressure monitoring is required before induction.
If magnesium has been used, expect prolongation of action of non-depolarising muscle relaxants. Use a reduced dose and assess muscle function with a nerve stimulator.
Ensure adequate analgesia before extubation. The hypertensive response to extubation may also need to be controlled with antihypertensive agents (e.g. labetalol 10–20mg).
Effective postoperative analgesia is required, but avoid NSAIDs as these patients are prone to renal impairment and may have impaired platelet count or function. When the proteinuria has resolved, which is often within 48hr, NSAIDs may be introduced.
Continue care in HDU or ICU.
Regional anaesthesia
Despite the depleted intravascular volume that occurs with severe pre-eclampsia, pre-eclamptic patients are actually less prone to the hypotensive consequences of regional anaesthesia than normal individuals. Spinal anaesthesia consistently produces better analgesia than epidural anaesthesia and should not be avoided.
As with regional analgesia, platelet count and if necessary clotting screen needs to be assessed (see above).
A reduced volume of preload should be used (possibly with colloid).
Expect ephedrine to have an increased effect. The role of phenylephrine in pre-eclamptic patients has still to be established.
A slow-onset block may be beneficial.
Effective postoperative analgesia is required, but avoid NSAIDs as these patients are prone to renal impairment and may have impaired platelet count or function.
Care should be continued on HDU or ICU.
Eclampsia
Incidence 1:3500 pregnancies in the UK,1 but there are wide international variations.
Most fits occur in the third trimester, and nearly one–third occur postpartum, usually within 24hr of delivery.
Eclampsia is a life-threatening event.
Management is aimed at immediate control of the fit and secondary prevention of further fits.
Immediate management
Airway (left lateral position with jaw thrust), breathing (bag and mask ventilation and measure oxygen saturation), circulation (obtain IV access and measure BP when possible, avoid aortocaval compression).
Control of fits with 4g magnesium given IV over 5–10min.
Prevention of further fits2
Magnesium infusion at 1g/hr for 24hr. Therapeutic level—2–4mmol/l. Magnesium levels may be monitored clinically [loss of reflexes (>5.0mmol/l), reduced respiratory rate (6.0–7.0mmol/l)] or with laboratory monitoring. Reduce infusion rate with oliguria. (Cardiac arrest may occur at >12.0mmol/l.)
Patients on calcium channel antagonists are at particular risk of toxicity.
Toxicity can be treated with IV calcium (e.g. 10ml 10% calcium chloride).
After the initial fit has been controlled, if eclampsia has developed antenatally a decision has to be made as to when delivery is to be performed. In general the patient should be stabilised on a magnesium infusion and then consideration given to vaginal or operative delivery. Eclampsia is not an indication for emergency Caesarean section. If general anaesthesia is required, expect prolongation of action of non-depolarising muscle relaxants. After delivery patients should be observed on HDU or ICU.
HELLP syndrome
Haemolysis, Elevated Liver enzymes and Low Platelets comprises the HELLP syndrome. It is usually associated with pre-eclampsia or eclampsia, but these are not a prerequisite for diagnosis. Severe HELLP syndrome has a 5% maternal mortality. HELLP rarely presents before the 20th week of gestation, but one-sixth of cases present before the third trimester and a further third present postnatally (usually within 48hr of delivery). Symptoms are sometimes of a vague flu-like illness, which may delay diagnosis. Maintain a high index of suspicion.
Features of HELLP
Evidence of haemolysis (a falling Hb concentration without evidence of overt bleeding, haemoglobinuria, elevated bilirubin in serum and urine, elevated LDH).
Elevated liver function tests—AST (serum aspartate transaminase), ALT (serum alanine aminotransferase), alkaline phosphatase, and γ-glutamyl transferase. Epigastric or right upper quadrant abdominal pain are present in 90% of women with HELLP. Liver failure and hepatic rupture may occur. Extreme elevation in AST is associated with poor maternal prognosis. Most women with right upper quadrant pain and a platelet count of <20 × 109/l will have an intrahepatic or subcapsular bleed.
A falling platelet count. Counts of less than 100 × 109/l are of concern, while a count of less than 50 × 109/l is indicative of severe disease.
Hypertension and proteinuria are present in 80% of women with HELLP and 50% suffer nausea and vomiting. Convulsions and gastrointestinal haemorrhage are occasional presenting features.
The only definitive treatment is delivery of the placenta, although high-dose steroids may delay progress of the disease. If maternal condition is not deteriorating rapidly and the fetus is profoundly premature, delivery may be delayed by 48hr to allow steroids to be administered to promote fetal lung maturity.
The method of delivery depends on maternal condition and the likelihood of successfully inducing labour. Severe HELLP syndrome will require an urgent Caesarean section.
The risk of epidural haematoma may preclude the use of regional analgesia/anaesthesia. Consideration must be given to both the absolute platelet number as well as rate of fall in platelet count. All patients require a clotting screen.
Be prepared for major haemorrhage.
Further management is supportive, with appropriate replacement of blood products as required.
Invasive monitoring is dictated entirely by the clinical condition of the patient.
ARDS, renal failure, and disseminated intravascular coagulation may develop.
After delivery of the placenta, recovery can be expected to start within 24–48hr. These patients should all be on an HDU or ICU.
Surgery during pregnancy
One to two percent of women require incidental surgery during pregnancy.1 Surgery is associated with increased fetal loss and premature delivery, although this probably reflects the underlying condition that necessitated the surgery rather than the anaesthetic or the surgery itself. The risk of teratogenicity is very small.
General considerations
When possible delay surgery until the postnatal period or alternatively into the second trimester, when teratogenic risks to the fetus are reduced (the fetus is at greatest risk from teratogenicity in the period of organogenesis, which continues to the 12th gestational week).
Make sure that the obstetric team are aware that surgery is planned.
Remember gastric acid prophylaxis.
Remember DVT prophylaxis. Pregnant women are hypercoagulable.
Consider regional anaesthesia. The combination of a mother maintaining her own airway together with a minimal fetal drug exposure is desirable. However, data demonstrating that regional anaesthesia is safer than general anaesthesia are lacking.
Airway management in the first and early second trimester is controversial. In asymptomatic women with no other indication for intubation, it is acceptable not to perform a rapid sequence induction up to 18wk of gestation. However, be aware that lower oesophageal sphincter tone is reduced within the first few weeks of pregnancy and intra-abdominal pressure rises in the second trimester. If patients have additional risk factors for regurgitation (e.g. symptomatic reflux, obesity), use a rapid sequence induction.2
Every effort must be made to maintain normal maternal physiological parameters for the gestational age of the fetus throughout the perioperative period.
Treat haemorrhage aggressively. Avoid hypovolaemia and anaemia as both impact on fetal oxygenation.
From the 20th week of gestation use left lateral tilt to reduce aortocaval compression. Remember that although upper limb BP may be normal, uterine blood flow may still be compromised in the supine position.
If general anaesthesia is employed, use adequate doses of inhalational agents. Light anaesthesia is associated with increased catecholamine release, which reduces placental blood flow. The tocolytic effect of inhalational agents is advantageous.
Fetal monitoring may be beneficial although its value remains unproven. If fetal distress is detected, maternal physiology can be manipulated to optimise uterine blood flow.
The primary risk to the fetus is premature labour in the postoperative period. Detection and suppression of premature labour is vital. Women should be told to report sensations of uterine contractions so that appropriate tocolytic therapy can be instituted.
Effective postoperative analgesia is required to reduce maternal catecholamine secretion. Although opioids can be used, they may result in maternal hypercarbia. Regional analgesia with local anaesthetic agents may be preferential. If this would prevent the mother from detecting uterine contractions, consider external uterine pressure transduction—‘tocodynamometry’. For minor surgery local anaesthesia and simple analgesics such as paracetamol and codeine may be used. Chronic dosage with NSAIDs should be avoided—in the first trimester because of increased fetal loss and in the third trimester because of the possibility of premature closure of the fetal ductus arteriosus.
Teratogenicity
The fetus is at greatest risk of teratogenesis in the period of major organogenesis. This is predominantly in the first 12wk of gestation, although minor abnormalities may still occur after this. Causes of teratogenicity are diverse and include infection, pyrexia, hypoxia, and acidosis as well as the better-recognised hazards of drugs and radiation. The association of drugs with teratogenicity is often difficult. Epidemiological studies have to be large to establish associations, while animal experiments may not reflect either human dose exposure or human physiology. Although none of the commonly used anaesthetic agents is a proven teratogen, specific concerns are addressed below.
Premedication
Benzodiazepines. Case reports have associated benzodiazepines with cleft lip formation, but this has not been substantiated by more recent studies. A single dose has never been associated with teratogenicity. Long-term administration may lead to neonatal withdrawal symptoms following delivery, and exposure just before delivery may cause neonatal drowsiness and hypotonia.
Ranitidine and cimetidine are not known to be harmful, but caution is advised with chronic exposure to cimetidine because of known androgenic effects in adults.
Induction agents
Thiopental. Clinical experience with thiopental suggests that this is a very safe drug to use, although formal studies have not been conducted.
Propofol is not teratogenic in animal studies. Its use in early human pregnancy has not been formally investigated. Propofol is safe to use during Caesarean section at term.
Etomidate is also not teratogenic in animal studies. It is a potent inhibitor of cortisol synthesis, and when used for Caesarean section, neonates have reduced cortisol concentrations.
Ketamine should be avoided in early pregnancy as it increases intrauterine pressure, resulting in fetal asphyxia. This increase in intrauterine pressure is not apparent in the third trimester.1
Inhalational agents
Halothane and isoflurane have been used extensively in pregnancy and are safe. At high concentrations, maternal blood pressure and cardiac output fall, resulting in a significant reduction in uterine blood flow. The halogenated vapours also cause uterine relaxation, which may be beneficial for surgery during pregnancy.
Despite early concerns, recent epidemiological studies suggest that nitrous oxide is safe. However, nitrous oxide is consistently teratogenic in Sprague Dawley rats if they are exposed to 50–75% concentrations for 24hr during their peak organogenic period. Given that anaesthesia can be safely delivered without nitrous oxide it is sensible to avoid this agent.
Muscle relaxants: because these agents are not lipophilic, only very small quantities cross the placenta and so fetal exposure is limited. These agents are safe to use.
Anticholinesterase inhibitors: these agents are highly ionised and so, like muscle relaxants, do not readily cross the placenta and are safe to use. Chronic use of pyridostigmine to treat myasthenia gravis may cause premature labour.
Analgesics
Opioids readily cross the placenta, but brief exposure is safe. Long-term exposure will cause symptoms of withdrawal when the fetus is delivered. Animal studies suggest possible fetal teratogenicity if prolonged hypercapnia or impaired feeding develop as side effects of opioid exposure.
Chronic exposure to NSAIDs in early pregnancy may be associated with increased fetal loss and in the third trimester may cause premature closure of the ductus arteriosus and persistent pulmonary hypertension of the newborn. Single doses are unlikely to be harmful. These agents are also used to suppress labour, particularly in the second trimester.
Bupivacaine and lidocaine are safe. When used near delivery, bupivacaine has no significant neonatal neurobehavioural effects, while lidocaine may have a mild effect. Cocaine abuse during pregnancy increases fetal loss and may increase the incidence of abnormalities in the genitourinary tract.
Cervical cerclage
Procedure . | Surgical treatment of incompetent cervical os . |
---|---|
Time | 20min |
Pain | + |
Position | Lithotomy |
Blood loss | Nil |
Practical techniques | Spinal/epidural. GA with RSI/cuffed ETT if >18wk gestation or reflux |
Procedure . | Surgical treatment of incompetent cervical os . |
---|---|
Time | 20min |
Pain | + |
Position | Lithotomy |
Blood loss | Nil |
Practical techniques | Spinal/epidural. GA with RSI/cuffed ETT if >18wk gestation or reflux |
An incompetent cervix may be caused by congenital abnormalities, cervical scarring, or hormonal imbalance. Premature dilation of the cervix and fetal loss may result, usually in the second trimester. Cervical cerclage is performed to prevent this premature dilation and is one of the commonest surgical procedures undertaken in pregnancy. Although occasionally inserted before conception, it is usually performed between the 14th and 26th week. Emergency cerclage may be required in the face of a dilating cervix and bulging membranes. Not surprisingly emergency treatment is less successful in maintaining a pregnancy than prophylactic cerclage.
Preoperative
The risks of cerclage include membrane rupture (more common if the membranes are already bulging), infection, haemorrhage, and inducing premature labour.
Careful assessment of airway, gestation, symptoms of reflux, and supine hypotension.
Remember antacid prophylaxis.
Explain risks of teratogenicity/spontaneous miscarriage (see p. 791).
Perioperative
Both regional and general anaesthesia may be used.
If general anaesthesia is used and uterine relaxation is required to allow bulging membranes to be reduced, the halogenated vapour concentration can be increased.
For regional anaesthesia, a T8–T10 level is required for intraoperative comfort. If uterine relaxation is required, 2–3 puffs of sublingual glyceryl trinitrate spray may be used and repeated as necessary, although transient hypotension is to be expected.
Postoperative
In the postoperative period women should be observed closely for premature labour.
Vaginal cervical cerclage sutures are usually removed at the 38th week of gestation.
Special considerations
Various permutations on cervical cerclage are available. These are broadly divided into transvaginal procedures and transabdominal procedures.
The transabdominal procedure requires two operations—one for insertion and another for a Caesarean section for delivery and removal of the suture. It also carries greater risk of ureteric involvement.
Transvaginal procedures are much more common. Shirodkar and McDonald procedures are the two commonest methods. They both require anaesthesia for insertion but can be removed without anaesthetic.
Controversies
Feeding in labour
In the 1950s the Confidential Enquiries into maternal deaths highlighted aspiration as a major cause of maternal death. As a result a policy of fasting during labour became widespread. Although airway problems continue to be implicated in maternal deaths, aspiration is now rare.
Fasting may adversely affect the progress of labour. Ketosis and hypoglycaemia are common when fasting is combined with the physical effort of labour. This may reduce the likelihood of a spontaneous vaginal delivery.
Scrutton randomised women to feeding or fasting in labour and found that ketosis and hypoglycaemia were less common when women were fed. However, gastric volume was greater in the fed group, and there was no difference in the duration of first or second stages of labour, oxytocic requirements, or mode of delivery.1
Most women do not want to eat when in established labour. However, if feeding is to be instituted, suggested recommendations are:
Only ‘low-risk’ women should be permitted to eat. However, identification of ‘low-risk’ women in early labour is notoriously inaccurate.
Stop all intake of solids if any opioid, epidural, or oxytocic is used.
Allow only ‘low residue’ foods that rapidly empty from the stomach (cereals, toast, low fat cheese, and semi-sweet biscuits). Very cold foods such as ice creams are known to delay gastric emptying.
As particulate matter is known to be especially problematic in the event of aspiration, isotonic sports drinks may offer the ideal solution. These effectively prevent ketosis without increasing gastric volume.
Epidurals, dystocia, and Caesarean section2
It has been recognised for many years that epidurals are associated with Caesarean section. However, argument continues as to whether this is a causative association. Various possible mechanisms have been proposed. These include:
Reduced maternal expulsive effort resulting from abdominal muscle weakness.
Change in the way the force of contraction is transferred to the pelvic floor when relaxed by an epidural.
Change in uterine force of contraction (this is not substantiated by recent studies).
Interference with the Ferguson reflex (increased oxytocic production between pressure on the pelvic floor in the second stage of labour). This is controversial, as the Ferguson reflex has not been clearly demonstrated in humans.
‘Impact studies’ (studies of changes in Caesarean section rates when there is a dramatic change in epidural rates) have not found a causative association.
Approximately 50% of randomised studies did find an association between assisted vaginal deliveries and regional analgesia. This may be minimised by reducing the total dose of local anaesthetic administered.
Bogod DG (1994). The postpartum stomach—when is it safe? Anaesthesia, 49, 1–2.
Anim-Somuah M, Smyth RMD, Howell CJ (2005). Epidural versus non-epidural or no analgesia in labour. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CDXXX331. DOI: 10.1002/14651858.CDXXX331.pub2.
McLure HA Talboys CA et al. (1998). Surgical face masks and downward dispersal of bacteria. Anaesthesia, 53, 624–626.
Morgan BM (1995). “Walking” epidurals in labour. Anaesthesia, 50, 839–840.
Reynolds F, Speedy H (1990). The subdural space: the third place to go astray. Anaesthesia, 45, 120–123.
Cook TM, Counsell D, Wildsmith JAW (2009). Major complications of central neuraxial block: report on the third national audit project of the Royal College of Anaesthetists. British Journal of Anaesthesia, 102, 179–190.
Sudlow C, Warlow C (2001). Epidural blood patching for preventing and treating postdural puncture headache. The Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: CD001791.
Reynolds F (1993). Dural puncture and headache. Avoid the first but treat the second. British Medical Journal, 306, 874–875.
Carrie LE (1993). Post dural puncture headache and extradural blood patch. British Journal of Anaesthesia, 71, 179–180.
Hinova A. Fernando R (2009). Systemic remifentanil for labor analgesia. Anesthesia and Analgesia, 109, 1925–1929.
Lucas DN, Yentis SM, et al. (2000). Urgency of Caesarean section: a new classification. Journal of the Royal Society of Medicine, 93, 346–350.
Hawkins JL, Koonin LM, et al. (1997). Anesthesia-related deaths during obstetric delivery in the United States, 1979–1990. Anesthesiology, 86, 277–284.
Russell IF (1995). Levels of anaesthesia and intraoperative pain at Caesarean section under regional block. International Journal of Obstetric Anesthesia, 4, 71–77.
Cook TM, Counsell D, Wildsmith JAW (2009). Major complications of central neuraxial block: report on the third national audit project of the Royal College of Anaesthetists. British Journal of Anaesthesia, 102, 179–190.
Harmer M (1997). Difficult and failed intubation in obstetrics. International Journal of Obstetric Anaesthesia, 6, 25–31.
Broadbent CR, Russell R (1999). What height of block is needed for manual removal of placenta under spinal anaesthesia? International Journal of Obstetric Anesthesia, 8, 161–164.
Lewis G (2008). The Confidential Enquiry into Maternal and Child Health (CEMACH 2003–2005) www.cemach.org
Abenhaim HA, Azoulay L, Kramer MS, Leduc L (2008). Incidence and risk factors of amniotic fluid embolism: a population-based study on 3 million births in the United States. American Journal of Obstetrics and Gynaecology, 199(49).e1–8
Duley L, Meher S Abalos E (2006). Management of pre-eclampsia. British Medical Journal, 332, 463–468.
Steegers AP et al. (2010). Pre-eclampsia. Lancet, 376, 631–44.
Knight M, on behalf of UKOSS (2007). Eclampsia in the United Kingdom 2005. British Journal of Obstetrics and Gynaecology, 114, 1072–1078.
The Eclampsia Trial Collaborative Group (1995). Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet, 345, 1455–1463.
Mazze RI, Kallen B (1989). Reproductive outcome after anesthesia and operation during pregnancy: A registry study of 5405 cases. American Journal of Obstetrics & Gynecology, 161, 1178–85.
Vanner RG (1992). Gastro-oesophageal reflux and regurgitation during general anaesthesia for termination of pregnancy. International Journal of Obstetric Anaesthesia, 1, 123–128.
Scrutton MJL, Metcalfe GA, et al. (1999). Eating in labour. A randomised controlled trial assessing the risks and benefits. Anaesthesia, 54, 329–334.
Chestnut DH (1997). Epidural analgesia and the incidence of cesarean section. Time for another close look. Anesthesiology, 87, 472–475.
Month: | Total Views: |
---|---|
October 2022 | 3 |
December 2022 | 4 |
January 2023 | 2 |
February 2023 | 4 |
March 2023 | 4 |
April 2023 | 3 |
May 2023 | 1 |
June 2023 | 2 |
July 2023 | 2 |
August 2023 | 2 |
September 2023 | 2 |
October 2023 | 2 |
November 2023 | 2 |
December 2023 | 2 |
February 2024 | 1 |
March 2024 | 3 |
April 2024 | 1 |
May 2024 | 1 |
June 2024 | 5 |
July 2024 | 3 |
August 2024 | 3 |
September 2024 | 2 |
February 2025 | 1 |